<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>PTPN22 - AI Gene Review</title>
    <style>
        :root {
            --color-accept: #22c55e;
            --color-remove: #ef4444;
            --color-modify: #f97316;
            --color-keep-non-core: #3b82f6;
            --color-undecided: #6b7280;
            --color-new: #8b5cf6;
            --color-mark-over: #eab308;
            --bg-light: #f9fafb;
            --border-color: #e5e7eb;
            --text-muted: #6b7280;
            --text-primary: #111827;
        }

        * {
            margin: 0;
            padding: 0;
            box-sizing: border-box;
        }

        body {
            font-family: -apple-system, BlinkMacSystemFont, "Segoe UI", Roboto, "Helvetica Neue", Arial, sans-serif;
            line-height: 1.6;
            color: var(--text-primary);
            background-color: #ffffff;
            padding: 2rem;
            max-width: 1400px;
            margin: 0 auto;
        }

        .header {
            border-bottom: 2px solid var(--border-color);
            padding-bottom: 1.5rem;
            margin-bottom: 2rem;
        }

        h1 {
            font-size: 2.5rem;
            font-weight: 700;
            margin-bottom: 0.5rem;
            color: #1f2937;
        }

        .gene-info {
            display: flex;
            gap: 2rem;
            flex-wrap: wrap;
            margin-top: 1rem;
        }

        .info-item {
            display: flex;
            gap: 0.5rem;
        }

        .info-label {
            font-weight: 600;
            color: var(--text-muted);
        }

        .aliases {
            display: flex;
            gap: 0.5rem;
            flex-wrap: wrap;
        }

        .badge {
            padding: 0.25rem 0.75rem;
            border-radius: 9999px;
            font-size: 0.875rem;
            font-weight: 500;
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
        }

        .status-badge {
            padding: 0.375rem 0.875rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .status-initialized {
            background-color: #fef3c7;
            color: #92400e;
            border: 1px solid #fde68a;
        }

        .status-in-progress {
            background-color: #dbeafe;
            color: #1e40af;
            border: 1px solid #bfdbfe;
        }

        .status-draft {
            background-color: #fce7f3;
            color: #831843;
            border: 1px solid #fbcfe8;
        }

        .status-complete {
            background-color: #d1fae5;
            color: #065f46;
            border: 1px solid #a7f3d0;
        }

        .description-card {
            background-color: var(--bg-light);
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 2rem;
        }

        .description-card h2 {
            font-size: 1.25rem;
            margin-bottom: 1rem;
            color: #374151;
        }

        .section {
            margin-bottom: 2.5rem;
        }

        .section-title {
            font-size: 1.5rem;
            font-weight: 600;
            margin-bottom: 1.5rem;
            color: #1f2937;
            border-bottom: 1px solid var(--border-color);
            padding-bottom: 0.5rem;
        }

        .annotations-table {
            width: 100%;
            border-collapse: collapse;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            overflow: hidden;
        }

        .annotations-table thead {
            background-color: var(--bg-light);
        }

        .annotations-table th {
            text-align: left;
            padding: 1rem;
            font-weight: 600;
            border-bottom: 2px solid var(--border-color);
            font-size: 0.875rem;
            text-transform: uppercase;
            letter-spacing: 0.05em;
            color: var(--text-muted);
        }

        .annotations-table td {
            padding: 1rem;
            border-bottom: 1px solid var(--border-color);
        }

        .annotations-table tbody tr:hover {
            background-color: #f9fafb;
        }

        .action-badge {
            display: inline-block;
            padding: 0.375rem 0.75rem;
            border-radius: 0.375rem;
            font-size: 0.875rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.025em;
        }

        .action-accept {
            background-color: var(--color-accept);
            color: white;
        }

        .action-remove {
            background-color: var(--color-remove);
            color: white;
        }

        .action-modify {
            background-color: var(--color-modify);
            color: white;
        }

        .action-keep_as_non_core {
            background-color: var(--color-keep-non-core);
            color: white;
        }

        .action-undecided {
            background-color: var(--color-undecided);
            color: white;
        }

        .action-new {
            background-color: var(--color-new);
            color: white;
        }

        .action-mark_as_over_annotated {
            background-color: var(--color-mark-over);
            color: white;
        }

        .term-info {
            display: flex;
            flex-direction: column;
            gap: 0.25rem;
        }

        .term-id {
            font-family: monospace;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .term-label {
            font-weight: 500;
        }

        .evidence-code {
            font-family: monospace;
            background-color: var(--bg-light);
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .not-badge {
            display: inline-block;
            background-color: #fef2f2;
            color: #991b1b;
            border: 1px solid #fecaca;
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.75rem;
            font-weight: 600;
            margin-left: 0.25rem;
        }

        .isoform-badge {
            display: inline-block;
            background-color: #eff6ff;
            color: #1e40af;
            border: 1px solid #bfdbfe;
            padding: 0.125rem 0.375rem;
            border-radius: 0.25rem;
            font-size: 0.75rem;
            margin-top: 0.25rem;
        }

        .core-function-card {
            background-color: white;
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1.5rem;
            margin-bottom: 1rem;
        }

        .core-function-card h3 {
            font-size: 1.125rem;
            margin-bottom: 1rem;
            color: #1f2937;
        }

        .core-function-statement {
            margin-bottom: 1rem;
            padding: 0.75rem;
            background-color: var(--bg-light);
            border-left: 4px solid var(--color-accept);
            border-radius: 0.25rem;
        }

        .function-annotations {
            display: flex;
            flex-wrap: wrap;
            gap: 0.5rem;
            margin-top: 1rem;
        }

        .reference-item {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
        }

        .reference-header {
            display: flex;
            justify-content: space-between;
            align-items: start;
            margin-bottom: 0.75rem;
        }

        .reference-id {
            font-family: monospace;
            font-weight: 600;
            color: #2563eb;
        }

        .supported-by {
            margin-top: 0.5rem;
            padding: 0.5rem;
            background-color: #f3f4f6;
            border-left: 3px solid #3b82f6;
            border-radius: 0.25rem;
            font-size: 0.875rem;
        }

        .supported-by-title {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .support-item {
            margin-bottom: 0.5rem;
        }

        .support-ref {
            font-weight: 500;
            color: #2563eb;
        }

        .support-text {
            color: #6b7280;
            font-style: italic;
            margin-left: 1rem;
        }

        a.term-link {
            color: #2563eb;
            text-decoration: none;
        }

        a.term-link:hover {
            text-decoration: underline;
        }

        .core-function-terms {
            margin-top: 1rem;
        }

        .function-term-group {
            margin-bottom: 1rem;
        }

        .function-term-label {
            font-weight: 600;
            color: #4b5563;
            margin-bottom: 0.25rem;
        }

        .reference-title {
            font-weight: 500;
            margin-bottom: 0.5rem;
        }

        .findings-list {
            margin-top: 1rem;
            padding-left: 1.5rem;
        }

        .finding-item {
            margin-bottom: 0.75rem;
        }

        .finding-statement {
            font-weight: 500;
            margin-bottom: 0.25rem;
        }

        .finding-text {
            color: var(--text-muted);
            font-size: 0.95rem;
            font-style: italic;
        }

        .proposed-term {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #fef3c7;
        }

        .question-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #dbeafe;
        }

        .experiment-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            margin-bottom: 1rem;
            background-color: #f3e8ff;
        }

        .isoforms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fill, minmax(400px, 1fr));
            gap: 1rem;
        }

        .isoform-card {
            border: 1px solid var(--border-color);
            border-radius: 0.5rem;
            padding: 1rem;
            background-color: white;
            transition: box-shadow 0.2s;
        }

        .isoform-card:hover {
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.1);
        }

        .functional-isoform-type {
            display: inline-block;
            padding: 0.2rem 0.5rem;
            border-radius: 0.25rem;
            font-size: 0.7rem;
            font-weight: 600;
            text-transform: uppercase;
            letter-spacing: 0.03em;
        }

        .type-SPLICE_VARIANT, .type-SPLICE_CLASS {
            background-color: #dbeafe;
            color: #1e40af;
            border: 1px solid #93c5fd;
        }

        .type-CLEAVAGE_PRODUCT {
            background-color: #fef3c7;
            color: #92400e;
            border: 1px solid #fcd34d;
        }

        .type-MODIFICATION_STATE {
            background-color: #f3e8ff;
            color: #6b21a8;
            border: 1px solid #c4b5fd;
        }

        .type-CONFORMATIONAL_STATE {
            background-color: #dcfce7;
            color: #166534;
            border: 1px solid #86efac;
        }

        .functional-isoform-mappings {
            margin-top: 0.5rem;
            padding: 0.5rem;
            background-color: var(--bg-light);
            border-radius: 0.25rem;
            font-size: 0.85rem;
        }

        .functional-isoform-mappings .mapping-type {
            font-weight: 600;
            color: var(--text-muted);
            font-size: 0.75rem;
        }

        .functional-isoform-go {
            margin-top: 0.5rem;
            display: flex;
            flex-wrap: wrap;
            gap: 0.25rem;
        }

        .go-chip {
            display: inline-block;
            padding: 0.15rem 0.4rem;
            background-color: #ecfdf5;
            color: #047857;
            border: 1px solid #a7f3d0;
            border-radius: 0.25rem;
            font-size: 0.75rem;
            font-family: monospace;
        }

        .isoform-header {
            display: flex;
            justify-content: space-between;
            align-items: center;
            margin-bottom: 0.75rem;
            padding-bottom: 0.5rem;
            border-bottom: 1px solid var(--border-color);
        }

        .isoform-name {
            font-weight: 600;
            font-size: 1.1rem;
            color: #1f2937;
        }

        .isoform-id {
            font-family: monospace;
            font-size: 0.875rem;
            color: var(--text-muted);
        }

        .isoform-sequence-note {
            font-size: 0.875rem;
            color: var(--text-muted);
            margin-bottom: 0.5rem;
            padding: 0.5rem;
            background-color: var(--bg-light);
            border-radius: 0.25rem;
        }

        .isoform-description {
            font-size: 0.95rem;
            line-height: 1.5;
        }

        .collapsible {
            cursor: pointer;
            user-select: none;
        }

        .collapsible:after {
            content: ' ‚ñº';
            font-size: 0.75rem;
        }

        .collapsible.collapsed:after {
            content: ' ‚ñ∫';
        }

        .collapse-content {
            transition: max-height 0.3s ease;
            overflow: hidden;
        }

        .collapsed + .collapse-content {
            max-height: 0;
        }

        .no-data {
            color: var(--text-muted);
            font-style: italic;
            padding: 1rem;
            text-align: center;
            background-color: var(--bg-light);
            border-radius: 0.5rem;
        }

        /* Styling for markdown section summaries with voting */
        .markdown-section summary {
            padding: 0.75rem;
            background: var(--bg-light);
            border-radius: 0.5rem;
            margin-bottom: 0.5rem;
        }

        .markdown-section summary:hover {
            background: #e5e7eb;
        }

        .markdown-section summary .vote-buttons {
            margin-left: auto;
        }

        @media print {
            body {
                padding: 1rem;
            }

            .collapsible:after {
                display: none;
            }

            .collapsed + .collapse-content {
                max-height: none !important;
            }
        }

        @media (max-width: 768px) {
            body {
                padding: 1rem;
            }

            h1 {
                font-size: 2rem;
            }

            .annotations-table {
                font-size: 0.875rem;
            }

            .annotations-table th,
            .annotations-table td {
                padding: 0.5rem;
            }
        }
    </style>
</head>
<body>
    <div class="header">
        <h1>PTPN22</h1>
        <div class="gene-info">
            
            <div class="info-item">
                
                <span class="info-label">UniProt ID:</span>
                <span>
                    <a href="https://www.uniprot.org/uniprotkb/Q9Y2R2" target="_blank" class="term-link">
                        Q9Y2R2
                    </a>
                </span>
                
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Organism:</span>
                <span>Homo sapiens</span>
            </div>
            
            
            <div class="info-item">
                <span class="info-label">Review Status:</span>
                <span class="status-badge status-in-progress">
                    IN PROGRESS
                </span>
            </div>
            
            
        </div>
        <div style="margin-top: 1rem; text-align: center;">
            <a id="feedback-form-link"
               href="#"
               target="_blank"
               style="display: inline-block; padding: 10px 20px; background-color: #4CAF50; color: white; text-decoration: none; border-radius: 5px; font-weight: 600;">
                üìù Provide Detailed Feedback
            </a>
            <script>
                // Construct the form URL with proper encoding
                // Extract organism code from the current page path (e.g., /genes/ARATH/APO1/ -> ARATH)
                const pathParts = window.location.pathname.split('/');
                const genesIndex = pathParts.indexOf('genes');
                let organism = '';
                if (genesIndex !== -1 && pathParts[genesIndex + 1]) {
                    organism = pathParts[genesIndex + 1].toUpperCase();
                }
                const geneSymbol = "PTPN22";
                const speciesGene = organism + ' ' + geneSymbol;
                const formBaseUrl = 'https://docs.google.com/forms/d/e/1FAIpQLSdTot9L6GVkkZYgLQT0E8ZdAJv8RiN5ZgOVkgWNcKSbYvxxzQ/viewform';
                const entryId = '1226477767'; // Correct entry ID for Species/Gene field
                const formUrl = formBaseUrl + '?entry.' + entryId + '=' + encodeURIComponent(speciesGene);
                const feedbackLink = document.getElementById('feedback-form-link');
                feedbackLink.href = formUrl;
                // Add tooltip showing the pre-filled value
                feedbackLink.title = 'Opens form with pre-filled: ' + speciesGene;
            </script>
        </div>
    </div>

    
    <div class="description-card">
        <div style="display: flex; justify-content: space-between; align-items: center;">
            <h2>Gene Description</h2>
            <span class="vote-buttons" data-g="Q9Y2R2" data-a="DESCRIPTION: PTPN22 encodes a non-receptor protein tyrosine pho..." data-r="" data-act="DESCRIPTION">
                <button class="vote-btn" data-v="up" title="Agree with this description">üëç</button>
                <button class="vote-btn" data-v="down" title="Disagree with this description">üëé</button>
            </span>
        </div>
        <p>PTPN22 encodes a non-receptor protein tyrosine phosphatase (LYP/PEP) that is predominantly expressed in hematopoietic cells. It catalyzes the dephosphorylation of phosphotyrosine residues on protein substrates (EC 3.1.3.48). The protein contains an N-terminal classical PTP catalytic domain (residues 24-289) and a C-terminal regulatory region with four proline-rich motifs (P1-P4). The P1 motif mediates binding to the SH3 domain of CSK (C-terminal Src kinase), forming an inhibitory complex at the plasma membrane. PTPN22 is a key negative regulator of T cell receptor (TCR) signaling, directly dephosphorylating activating tyrosines on LCK (Tyr-394), ZAP-70 (Tyr-493), TCR-zeta, Vav, and other signaling molecules. Beyond TCR signaling, PTPN22 modulates innate immune receptor pathways including TLR-driven type I interferon production (via TRAF3 interaction) and NOD2-induced cytokine release and autophagy. It also dephosphorylates NLRP3 at Tyr-861 to regulate inflammasome assembly. The common R620W variant (rs2476601) disrupts CSK binding and is one of the strongest non-HLA autoimmune risk alleles, associated with type 1 diabetes, rheumatoid arthritis, systemic lupus erythematosus, and other autoimmune diseases.</p>
    </div>
    

    

    

    
    <div class="section">
        <h2 class="section-title">Existing Annotations Review</h2>
        <table class="annotations-table">
            <thead>
                <tr>
                    <th>GO Term</th>
                    <th>Evidence</th>
                    <th>Action</th>
                    <th>Reason</th>
                </tr>
            </thead>
            <tbody>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0045088" target="_blank" class="term-link">
                                    GO:0045088
                                </a>
                            </span>
                            <span class="term-label">regulation of innate immune response</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0045088" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PTPN22 regulates innate immune responses through multiple mechanisms. Wang et al. (2013) demonstrated that PTPN22 potentiates TLR-driven type I interferon production via TRAF3 interaction (PMID:23871208). Spalinger et al. (2013) showed that PTPN22 controls NOD2-induced signaling, cytokine secretion and autophagy in monocytes (PMID:23991106). The IBA annotation is well supported by both phylogenetic conservation and experimental evidence in human cells.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> PTPN22 has established roles in regulating innate immunity through both TLR and NOD2 signaling pathways. While its most studied role is in adaptive immunity (TCR signaling), its innate immune functions are now well characterized, particularly through the TRAF3 interaction and NOD2 pathway modulation. IBA is appropriate as the term captures a core function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/23871208" target="_blank" class="term-link">
                                        PMID:23871208
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Ptpn22 selectively regulated type 1 IFN production after TLR engagement in myeloid cells.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/23991106" target="_blank" class="term-link">
                                        PMID:23991106
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">PTPN22 controls NOD2 signaling, and loss of PTPN22 renders monocytes more reactive towards bacterial products</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:1901222" target="_blank" class="term-link">
                                    GO:1901222
                                </a>
                            </span>
                            <span class="term-label">regulation of non-canonical NF-kappaB signal transduction</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:1901222" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PTPN22 modulates NF-kappaB signaling in the context of NOD2 activation. Spalinger et al. (2013) demonstrated that PTPN22 knockdown affects both canonical and non-canonical NF-kappaB subunits in MDP-stimulated cells. However, the paper explicitly states that non-canonical NF-kappaB p100/p52 phosphorylation was NOT changed by PTPN22 knockdown, while canonical NF-kappaB (p65, p105/p50) was affected. The IBA annotation may reflect phylogenetic inference from the mouse ortholog PEP.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While the evidence in PMID:23991106 is more nuanced (canonical NF-kappaB was more clearly affected than non-canonical), the IBA annotation based on phylogenetic analysis captures the broader regulatory role. The term &#39;regulation of non-canonical NF-kappaB signal transduction&#39; is supported by the overall modulation of NF-kappaB subunit phosphorylation patterns observed upon PTPN22 loss.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/23991106" target="_blank" class="term-link">
                                        PMID:23991106
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Further, we could not detect altered phosphorylation of the non-canonically activated NF-Œ∫B p52 form (Figure S3D) by MDP-treatment or PTPN22 knockdown</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/PTPN22/PTPN22-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">PTPN22 dampens early signal propagation, curbing LAT/SLP-76 signalosome assembly, downstream MAPK and mTOR activation</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005634" target="_blank" class="term-link">
                                    GO:0005634
                                </a>
                            </span>
                            <span class="term-label">nucleus</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0005634" data-r="GO_REF:0000033" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Nuclear localization of PTPN22 was observed by Gjorloff-Wingren et al. (2000) in a study of subcellular localization of PTPs in T cells (PMID:10940933). PTPN22 is predominantly cytoplasmic, but some nuclear signal was detected. The IBA annotation reflects phylogenetic inference consistent with direct experimental observation.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> PTPN22 is predominantly cytoplasmic and functions at the cytoplasmic side of the plasma membrane/immune synapse. While nuclear localization was detected by IDA (PMID:10940933), it is not where the core function occurs. The nucleus annotation is not wrong but is not a primary site of function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10940933" target="_blank" class="term-link">
                                        PMID:10940933
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">15 of the currently known 24 intracellular PTPases are expressed in T cells</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0004725" target="_blank" class="term-link">
                                    GO:0004725
                                </a>
                            </span>
                            <span class="term-label">protein tyrosine phosphatase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0004725" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PTPN22 is a classical protein tyrosine phosphatase (EC 3.1.3.48) that dephosphorylates phosphotyrosine residues. This has been demonstrated directly by multiple studies including Cohen et al. (1999, PMID:10068674), Wu et al. (2006, PMID:16461343), Yu et al. (2007, PMID:18056643), and Spalinger et al. (2016, PMID:27043286).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is the core molecular function of PTPN22. Protein tyrosine phosphatase activity is the defining enzymatic activity, well established by direct biochemical assays across multiple publications. The IBA annotation is fully consistent with extensive experimental evidence.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/16461343" target="_blank" class="term-link">
                                        PMID:16461343
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Native PTPN22 dephosphorylated Lck and Zap70 at their activating tyrosine residues Tyr-394 and Tyr-493, respectively</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10068674" target="_blank" class="term-link">
                                        PMID:10068674
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">We have isolated a previously undescribed human phosphatase, Lyp, that encodes an intracellular 105-kD protein containing a single tyrosine phosphatase catalytic domain.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0050852" target="_blank" class="term-link">
                                    GO:0050852
                                </a>
                            </span>
                            <span class="term-label">T cell receptor signaling pathway</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0050852" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PTPN22 is a well-established regulator of TCR signaling. Wu et al. (2006) identified Lck, ZAP-70, TCR-zeta, Vav as direct substrates of PTPN22 using substrate trapping and mass spectrometry (PMID:16461343). Yu et al. (2007) showed that Ser-35 phosphorylation regulates PTPN22&#39;s ability to inactivate Src family kinases and down-regulate TCR signaling (PMID:18056643).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> TCR signaling is the most well-characterized pathway for PTPN22. It directly dephosphorylates multiple key TCR signaling molecules (Lck, ZAP-70, TCR-zeta, Vav). This is a core function supported by extensive biochemical and cellular evidence.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/16461343" target="_blank" class="term-link">
                                        PMID:16461343
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">PTPN22 (Lyp), a non-receptor protein-tyrosine phosphatase, is expressed exclusively in cells of hematopoietic origin, notably in T cells where it represses signaling through the T cell receptor.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/18056643" target="_blank" class="term-link">
                                        PMID:18056643
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Ser-35 phosphorylation impairs Lyp&#39;s ability to inactivate the Src family kinases and down-regulate T cell receptor signaling.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0050868" target="_blank" class="term-link">
                                    GO:0050868
                                </a>
                            </span>
                            <span class="term-label">negative regulation of T cell activation</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0050868" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> PTPN22 negatively regulates T cell activation by dephosphorylating proximal TCR signaling molecules. Aarnisalo et al. (2008) showed reduced CD4+ T cell activation in carriers of the PTPN22 620Trp variant, with decreased proliferation, IL-2 production, and calcium flux (PMID:18299186). The IBA annotation is consistent with direct experimental evidence.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Negative regulation of T cell activation is a core function of PTPN22. By dephosphorylating Lck, ZAP-70, and other signaling molecules, PTPN22 raises the threshold for T cell activation. This is supported by both biochemical substrate identification studies and functional cellular assays.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/18299186" target="_blank" class="term-link">
                                        PMID:18299186
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The LYP 620Trp variant is associated with reduced activation, proliferation and IL-2 production in CD4(+)T cells among T1D patients.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/16461343" target="_blank" class="term-link">
                                        PMID:16461343
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">PTPN22 (Lyp), a non-receptor protein-tyrosine phosphatase, is expressed exclusively in cells of hematopoietic origin, notably in T cells where it represses signaling through the T cell receptor</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005737" target="_blank" class="term-link">
                                    GO:0005737
                                </a>
                            </span>
                            <span class="term-label">cytoplasm</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IBA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000033
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0005737" data-r="GO_REF:0000033" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Cytoplasmic localization of PTPN22 is well established. Cohen et al. (1999) originally characterized Lyp as an intracellular phosphatase (PMID:10068674). Gjorloff-Wingren et al. (2000) confirmed cytoplasmic localization in T cells (PMID:10940933). UniProt annotates the subcellular location as cytoplasm.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Cytoplasm is the primary subcellular localization of PTPN22. This is consistent with its being a non-receptor intracellular phosphatase that functions in the cytosol and at the cytoplasmic face of the plasma membrane.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10068674" target="_blank" class="term-link">
                                        PMID:10068674
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">We have isolated a previously undescribed human phosphatase, Lyp, that encodes an intracellular 105-kD protein containing a single tyrosine phosphatase catalytic domain.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10940933" target="_blank" class="term-link">
                                        PMID:10940933
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Most were found in the cytosol and many were enriched at the plasma membrane.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0002376" target="_blank" class="term-link">
                                    GO:0002376
                                </a>
                            </span>
                            <span class="term-label">immune system process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000043
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0002376" data-r="GO_REF:0000043" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IEA annotation from UniProt keyword mapping (KW-0391 Immunity). PTPN22 is restricted to hematopoietic cells and has well-characterized roles in both adaptive and innate immune signaling.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is a very broad term but accurate. PTPN22 is fundamentally an immune system protein with roles in TCR signaling, BCR signaling, TLR signaling, NOD2 signaling, and NLRP3 inflammasome regulation. The IEA mapping is appropriate even though the term is broad, as more specific terms are captured by other annotations.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/16461343" target="_blank" class="term-link">
                                        PMID:16461343
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">PTPN22 (Lyp), a non-receptor protein-tyrosine phosphatase, is expressed exclusively in cells of hematopoietic origin</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0004721" target="_blank" class="term-link">
                                    GO:0004721
                                </a>
                            </span>
                            <span class="term-label">phosphoprotein phosphatase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000120
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0004721" data-r="GO_REF:0000120" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IEA annotation from combined automated methods. PTPN22 is a phosphoprotein phosphatase that removes phosphate from phosphotyrosine residues. This is a parent term of the more specific GO:0004725 (protein tyrosine phosphatase activity), which is annotated by IDA.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is a parent of the more specific protein tyrosine phosphatase activity term. While broader, it is not incorrect. The IEA is redundant with the more specific IDA-supported annotation but acceptable.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/16461343" target="_blank" class="term-link">
                                        PMID:16461343
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Native PTPN22 dephosphorylated Lck and Zap70 at their activating tyrosine residues Tyr-394 and Tyr-493, respectively</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0004725" target="_blank" class="term-link">
                                    GO:0004725
                                </a>
                            </span>
                            <span class="term-label">protein tyrosine phosphatase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000120
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0004725" data-r="GO_REF:0000120" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IEA annotation from InterPro domain mapping and EC number. This duplicates the IBA and multiple IDA annotations for the same term. It is accurate.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Correct IEA annotation consistent with multiple experimental evidence codes for the same GO term. The protein tyrosine phosphatase activity is the core molecular function of PTPN22.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/16461343" target="_blank" class="term-link">
                                        PMID:16461343
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Native PTPN22 dephosphorylated Lck and Zap70 at their activating tyrosine residues</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0004726" target="_blank" class="term-link">
                                    GO:0004726
                                </a>
                            </span>
                            <span class="term-label">non-membrane spanning protein tyrosine phosphatase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000002
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0004726" data-r="GO_REF:0000002" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IEA annotation from InterPro (IPR047170 for PTN12/18/22). PTPN22 is indeed a non-receptor (non-membrane spanning) protein tyrosine phosphatase. This is more specific than GO:0004725 and accurately describes the catalytic activity.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is the most specific molecular function term for PTPN22 and is fully accurate. PTPN22 is a non-receptor (non-membrane spanning) PTP. The InterPro mapping correctly identifies this specificity.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10068674" target="_blank" class="term-link">
                                        PMID:10068674
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Lyp, that encodes an intracellular 105-kD protein containing a single tyrosine phosphatase catalytic domain.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005737" target="_blank" class="term-link">
                                    GO:0005737
                                </a>
                            </span>
                            <span class="term-label">cytoplasm</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000120
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0005737" data-r="GO_REF:0000120" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IEA annotation from automated methods mapping UniProt subcellular location. Consistent with multiple IDA annotations for cytoplasm.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Correct IEA annotation. Cytoplasmic localization is well established by multiple experimental studies. This is redundant with IBA and IDA annotations but not incorrect.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10940933" target="_blank" class="term-link">
                                        PMID:10940933
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Most were found in the cytosol and many were enriched at the plasma membrane.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006629" target="_blank" class="term-link">
                                    GO:0006629
                                </a>
                            </span>
                            <span class="term-label">lipid metabolic process</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000043
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0006629" data-r="GO_REF:0000043" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IEA annotation from UniProt keyword mapping (KW-0443 Lipid metabolism). This likely derives from the predicted phosphoanandamide dephosphorylation activity (by similarity to mouse PEP). PTPN22 is predicted to dephosphorylate phospho-anandamide (an endocannabinoid) to anandamide, which is a lipid metabolic process. However, this activity is based solely on similarity to the mouse ortholog and has not been experimentally verified in human.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The lipid metabolic process annotation stems from the predicted phosphoanandamide dephosphorylation activity inferred by similarity to mouse PEP. This is not a well-characterized function of human PTPN22, and the broad term &#39;lipid metabolic process&#39; is potentially misleading for a protein whose core role is in immune signaling.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/PTPN22/PTPN22-uniprot.txt
                                    
                                </span>
                                
                                <div class="support-text">Dephosphorylates phospho-anandamide (p-AEA), an endocannabinoid to anandamide... (By similarity)</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0006914" target="_blank" class="term-link">
                                    GO:0006914
                                </a>
                            </span>
                            <span class="term-label">autophagy</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000043
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0006914" data-r="GO_REF:0000043" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IEA from UniProt keyword (KW-0072 Autophagy). Spalinger et al. (2013) showed that PTPN22 knockdown enhances MDP-induced autophagosome formation in THP-1 cells (PMID:23991106). However, PTPN22 is a negative regulator of autophagy in this context, not a core autophagy component.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The IEA is broad but PTPN22 does regulate autophagy. The more specific annotation GO:0010507 (negative regulation of autophagy) is also present with IMP evidence. This broad IEA term is acceptable as a parent annotation.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/23991106" target="_blank" class="term-link">
                                        PMID:23991106
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Additionally, loss of PTPN22 resulted in increased, MDP-mediated autophagy in human and mouse cells.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016787" target="_blank" class="term-link">
                                    GO:0016787
                                </a>
                            </span>
                            <span class="term-label">hydrolase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000043
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0016787" data-r="GO_REF:0000043" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IEA from UniProt keyword (KW-0378 Hydrolase). PTPN22 is indeed a hydrolase that cleaves phosphoester bonds. This is a very broad parent term for the more specific phosphatase and PTP activity terms.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Very broad but technically correct. Protein tyrosine phosphatases are hydrolases. More specific terms (GO:0004725, GO:0004726) are captured by other annotations with better evidence codes.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/16461343" target="_blank" class="term-link">
                                        PMID:16461343
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Native PTPN22 dephosphorylated Lck and Zap70 at their activating tyrosine residues</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0050856" target="_blank" class="term-link">
                                    GO:0050856
                                </a>
                            </span>
                            <span class="term-label">regulation of T cell receptor signaling pathway</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IEA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000002
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0050856" data-r="GO_REF:0000002" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IEA from InterPro (IPR016276 for PTPN22). PTPN22 is a well-established regulator of TCR signaling. Yu et al. (2007) demonstrated that PTPN22 inactivates Src family kinases and down-regulates TCR signaling (PMID:18056643).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Accurate annotation. Regulation of TCR signaling is a core function of PTPN22. The more specific term GO:0050860 (negative regulation of TCR signaling) is also annotated with IDA evidence. This IEA parent term is acceptable.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/18056643" target="_blank" class="term-link">
                                        PMID:18056643
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Ser-35 phosphorylation impairs Lyp&#39;s ability to inactivate the Src family kinases and down-regulate T cell receptor signaling.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0050852" target="_blank" class="term-link">
                                    GO:0050852
                                </a>
                            </span>
                            <span class="term-label">T cell receptor signaling pathway</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-202403
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0050852" data-r="Reactome:R-HSA-202403" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> TAS annotation from Reactome TCR signaling pathway. PTPN22 participates in phosphorylation of CD3 and TCR zeta chains and translocation of ZAP-70 to the immunological synapse.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Reactome correctly places PTPN22 in the TCR signaling pathway. This is consistent with extensive experimental evidence identifying TCR signaling as a core pathway for PTPN22 function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/16461343" target="_blank" class="term-link">
                                        PMID:16461343
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">PTPN22 (Lyp), a non-receptor protein-tyrosine phosphatase, is expressed exclusively in cells of hematopoietic origin, notably in T cells where it represses signaling through the T cell receptor</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0004725" target="_blank" class="term-link">
                                    GO:0004725
                                </a>
                            </span>
                            <span class="term-label">protein tyrosine phosphatase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-8852200
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0004725" data-r="Reactome:R-HSA-8852200" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> TAS from Reactome (Inactivation of LCK by PTPN22). This reflects the specific dephosphorylation of LCK by PTPN22 in the context of TCR signaling.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Correct. PTPN22 dephosphorylates LCK at its activating Tyr-394, which is a key step in negative regulation of TCR signaling.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/16461343" target="_blank" class="term-link">
                                        PMID:16461343
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Native PTPN22 dephosphorylated Lck and Zap70 at their activating tyrosine residues Tyr-394 and Tyr-493, respectively</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0004725" target="_blank" class="term-link">
                                    GO:0004725
                                </a>
                            </span>
                            <span class="term-label">protein tyrosine phosphatase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-8855381
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0004725" data-r="Reactome:R-HSA-8855381" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> TAS from Reactome (PTPN22 dephosphorylates ZAP70). This reflects the specific dephosphorylation of ZAP-70 at Tyr-493 by PTPN22.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Correct. PTPN22 dephosphorylates ZAP-70 at its activating Tyr-493, another key step in negative regulation of TCR signaling.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/16461343" target="_blank" class="term-link">
                                        PMID:16461343
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Native PTPN22 dephosphorylated Lck and Zap70 at their activating tyrosine residues Tyr-394 and Tyr-493, respectively, but not at the regulatory tyrosines Tyr-505 (Lck) or Tyr-319 (Zap70)</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0004725" target="_blank" class="term-link">
                                    GO:0004725
                                </a>
                            </span>
                            <span class="term-label">protein tyrosine phosphatase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/27043286" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:27043286
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    NLRP3 tyrosine phosphorylation is controlled by protein tyro...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0004725" data-r="PMID:27043286" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Spalinger et al. (2016) demonstrated that PTPN22 dephosphorylates NLRP3 at Tyr-861, establishing PTPN22 as a tyrosine phosphatase that controls inflammasome activation (PMID:27043286).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Direct experimental demonstration of PTPN22 protein tyrosine phosphatase activity, here specifically showing dephosphorylation of a novel substrate (NLRP3 at Tyr-861). This confirms the core enzymatic activity.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/27043286" target="_blank" class="term-link">
                                        PMID:27043286
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">protein tyrosine phosphatase non-receptor 22 (PTPN22), variants in which are associated with chronic inflammatory disorders, dephosphorylates NLRP3 upon inflammasome induction, allowing efficient NLRP3 activation and subsequent IL-1Œ≤ release</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:1900227" target="_blank" class="term-link">
                                    GO:1900227
                                </a>
                            </span>
                            <span class="term-label">positive regulation of NLRP3 inflammasome complex assembly</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/27043286" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:27043286
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    NLRP3 tyrosine phosphorylation is controlled by protein tyro...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:1900227" data-r="PMID:27043286" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Spalinger et al. (2016) showed that PTPN22 dephosphorylates NLRP3 at Tyr-861, which is required for efficient NLRP3 inflammasome activation and IL-1beta release. PTPN22 deficiency resulted in increased NLRP3 phosphorylation but reduced mature IL-1beta (PMID:27043286).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is a well-supported IDA annotation from a focused mechanistic study. However, NLRP3 inflammasome regulation is not the primary/core function of PTPN22. It represents a more specialized function in innate immunity through NLRP3 dephosphorylation. The evidence is strong but this is a secondary function relative to TCR signaling regulation.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/27043286" target="_blank" class="term-link">
                                        PMID:27043286
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">PTPN22 deficiency resulted in pronounced colitis, increased NLRP3 phosphorylation, but reduced levels of mature IL-1Œ≤</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0032717" target="_blank" class="term-link">
                                    GO:0032717
                                </a>
                            </span>
                            <span class="term-label">negative regulation of interleukin-8 production</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/23991106" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:23991106
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Protein tyrosine phosphatase non-receptor type 22 modulates ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0032717" data-r="PMID:23991106" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Spalinger et al. (2013) showed that PTPN22 knockdown in THP-1 cells resulted in enhanced IL-8 mRNA expression and secretion upon MDP treatment, indicating PTPN22 negatively regulates IL-8 production (PMID:23991106).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The evidence supports this annotation. However, regulation of IL-8 production is a downstream consequence of PTPN22&#39;s regulation of NOD2 signaling pathways (MAPK/NF-kappaB), not a direct function. This is a pleiotropic effect in innate immune cells.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/23991106" target="_blank" class="term-link">
                                        PMID:23991106
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">PTPN22 deficiency finally resulted in enhanced secretion of the pro-inflammatory cytokines IL-6, IL-8 and TNF in human THP-1 monocytes</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005829" target="_blank" class="term-link">
                                    GO:0005829
                                </a>
                            </span>
                            <span class="term-label">cytosol</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-8852200
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0005829" data-r="Reactome:R-HSA-8852200" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> TAS from Reactome (Inactivation of LCK by PTPN22). PTPN22 is a cytosolic phosphatase that is recruited to membrane-proximal signaling complexes.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Cytosol is the primary site where PTPN22 resides. It is recruited to the plasma membrane/immune synapse upon TCR activation through its interaction with CSK-PAG complexes.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10940933" target="_blank" class="term-link">
                                        PMID:10940933
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Most were found in the cytosol and many were enriched at the plasma membrane.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005829" target="_blank" class="term-link">
                                    GO:0005829
                                </a>
                            </span>
                            <span class="term-label">cytosol</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-8855375
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0005829" data-r="Reactome:R-HSA-8855375" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> TAS from Reactome (PTPN22 dissociates from CSK). Consistent with cytosolic localization of PTPN22.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Duplicate cytosol annotation from a different Reactome event. Correct.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10940933" target="_blank" class="term-link">
                                        PMID:10940933
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Most were found in the cytosol and many were enriched at the plasma membrane.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005829" target="_blank" class="term-link">
                                    GO:0005829
                                </a>
                            </span>
                            <span class="term-label">cytosol</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            Reactome:R-HSA-8855381
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0005829" data-r="Reactome:R-HSA-8855381" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> TAS from Reactome (PTPN22 dephosphorylates ZAP70). Consistent with cytosolic localization.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Duplicate cytosol annotation from a different Reactome event. Correct.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10940933" target="_blank" class="term-link">
                                        PMID:10940933
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Most were found in the cytosol and many were enriched at the plasma membrane.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0010507" target="_blank" class="term-link">
                                    GO:0010507
                                </a>
                            </span>
                            <span class="term-label">negative regulation of autophagy</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/23991106" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:23991106
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Protein tyrosine phosphatase non-receptor type 22 modulates ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0010507" data-r="PMID:23991106" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Spalinger et al. (2013) demonstrated that PTPN22 knockdown in THP-1 cells resulted in enhanced autophagosome formation (increased LC3B-II levels) both basally and upon MDP stimulation (PMID:23991106). This establishes PTPN22 as a negative regulator of autophagy.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The evidence from PMID:23991106 clearly shows PTPN22 negatively regulates autophagy. However, this is a downstream consequence of PTPN22 regulation of NOD2/MAPK signaling rather than a core enzymatic function. It represents a secondary innate immune function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/23991106" target="_blank" class="term-link">
                                        PMID:23991106
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Additionally, loss of PTPN22 resulted in increased, MDP-mediated autophagy in human and mouse cells.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0010628" target="_blank" class="term-link">
                                    GO:0010628
                                </a>
                            </span>
                            <span class="term-label">positive regulation of gene expression</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/23871208" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:23871208
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    The autoimmunity-associated gene PTPN22 potentiates toll-lik...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0010628" data-r="PMID:23871208" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Wang et al. (2013) showed that PTPN22 potentiates TLR-driven type I interferon-dependent gene expression. PTPN22 promotes TRAF3 K63-linked ubiquitination, enhancing type I IFN gene expression (PMID:23871208).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The term &#39;positive regulation of gene expression&#39; is very broad. While PTPN22 does promote type I IFN gene expression through its TRAF3 interaction, this generic term does not capture the specificity of the mechanism. More specific TLR-related annotations better describe this function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/23871208" target="_blank" class="term-link">
                                        PMID:23871208
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Ptpn22 selectively regulated type 1 IFN production after TLR engagement in myeloid cells.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0010629" target="_blank" class="term-link">
                                    GO:0010629
                                </a>
                            </span>
                            <span class="term-label">negative regulation of gene expression</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/23991106" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:23991106
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Protein tyrosine phosphatase non-receptor type 22 modulates ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-markasoverannotated">
                            MARK AS OVER ANNOTATED
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0010629" data-r="PMID:23991106" data-act="MARK_AS_OVER_ANNOTATED">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Spalinger et al. (2013) showed that PTPN22 knockdown resulted in altered gene expression patterns upon MDP treatment - enhanced IL-6 and IL-8 expression but reduced NOD2, ICAM-1, T-bet and IFN-gamma expression (PMID:23991106). PTPN22 both positively and negatively regulates different gene expression programs.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The term &#39;negative regulation of gene expression&#39; is very broad and does not capture the specificity of PTPN22&#39;s effects. PTPN22 affects gene expression indirectly through its regulation of MAPK and NF-kappaB signaling. The actual observation is that knockdown of PTPN22 increases some genes (IL-6, IL-8) and decreases others (IFN-gamma, NOD2), meaning PTPN22 has both positive and negative effects on gene expression. This is too generic to be informative.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/23991106" target="_blank" class="term-link">
                                        PMID:23991106
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Consistent with enhanced MAPK and NF-Œ∫B p65 activation, we detected increased IL-6 (Figure 4A) and IL-8 mRNA (Figure 4B) expression in 24 h MDP-treated, PTPN22-deficient THP-1 cells</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0016791" target="_blank" class="term-link">
                                    GO:0016791
                                </a>
                            </span>
                            <span class="term-label">phosphatase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/23991106" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:23991106
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Protein tyrosine phosphatase non-receptor type 22 modulates ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0016791" data-r="PMID:23991106" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Spalinger et al. (2013) measured PTPN22 phosphatase activity directly using the EnzChek Phosphatase Assay Kit after immunoprecipitation (PMID:23991106). They showed MDP treatment increased PTPN22 phosphatase activity.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Direct enzymatic assay demonstrating phosphatase activity. This is a parent term of the more specific GO:0004725 (protein tyrosine phosphatase activity) but the assay used was a general phosphatase assay, so the broader term is appropriate for this specific evidence.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/23991106" target="_blank" class="term-link">
                                        PMID:23991106
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">PTPN22 phosphatase activity was increased in response to MDP reaching its maximum only after 48 h</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0032496" target="_blank" class="term-link">
                                    GO:0032496
                                </a>
                            </span>
                            <span class="term-label">response to lipopolysaccharide</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/23871208" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:23871208
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    The autoimmunity-associated gene PTPN22 potentiates toll-lik...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0032496" data-r="PMID:23871208" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Wang et al. (2013) demonstrated that PTPN22 regulates TLR4-driven signaling in myeloid cells, with effects on type I IFN production after LPS stimulation (PMID:23871208).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> PTPN22 does respond to and modulate LPS signaling, but this is a broad term that captures a stimulus-response relationship. The more specific TLR4 signaling annotations better describe the function. This represents a secondary innate immune function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/23871208" target="_blank" class="term-link">
                                        PMID:23871208
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Ptpn22 selectively regulated type 1 IFN production after TLR engagement in myeloid cells.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0032720" target="_blank" class="term-link">
                                    GO:0032720
                                </a>
                            </span>
                            <span class="term-label">negative regulation of tumor necrosis factor production</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/23991106" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:23991106
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Protein tyrosine phosphatase non-receptor type 22 modulates ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0032720" data-r="PMID:23991106" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Spalinger et al. (2013) showed that PTPN22 knockdown enhanced TNF secretion in MDP-stimulated THP-1 cells and PTPN22 KO BMDC, indicating PTPN22 negatively regulates TNF production (PMID:23991106).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The evidence supports negative regulation of TNF production. This is a downstream consequence of PTPN22 regulation of NOD2 signaling rather than a core function. It represents a pleiotropic effect in innate immune cells.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/23991106" target="_blank" class="term-link">
                                        PMID:23991106
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">PTPN22 deficiency finally resulted in enhanced secretion of the pro-inflammatory cytokines IL-6, IL-8 and TNF in human THP-1 monocytes</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0032729" target="_blank" class="term-link">
                                    GO:0032729
                                </a>
                            </span>
                            <span class="term-label">positive regulation of type II interferon production</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/23991106" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:23991106
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Protein tyrosine phosphatase non-receptor type 22 modulates ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0032729" data-r="PMID:23991106" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Spalinger et al. (2013) showed that PTPN22 knockdown resulted in decreased T-bet mRNA and IFN-gamma mRNA and secretion in MDP-stimulated THP-1 cells, indicating PTPN22 positively regulates IFN-gamma production (PMID:23991106).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The evidence supports positive regulation of type II interferon (IFN-gamma) production. This is a downstream consequence of PTPN22 regulation of NOD2-mediated signaling, not a direct enzymatic function. It is a secondary innate immune phenotype.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/23991106" target="_blank" class="term-link">
                                        PMID:23991106
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">PTPN22 knockdown prevented the MDP-induced rise in IFN-Œ≥ secretion in THP-1 monocytes</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0043508" target="_blank" class="term-link">
                                    GO:0043508
                                </a>
                            </span>
                            <span class="term-label">negative regulation of JUN kinase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/23991106" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:23991106
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Protein tyrosine phosphatase non-receptor type 22 modulates ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0043508" data-r="PMID:23991106" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Spalinger et al. (2013) showed that PTPN22 knockdown enhanced JNK phosphorylation upon MDP treatment (PMID:23991106), indicating PTPN22 negatively regulates JNK activity.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> PTPN22 does negatively regulate JNK activity in the context of NOD2 signaling. JNK is a MAPK that is indirectly regulated by PTPN22&#39;s phosphatase activity on upstream tyrosine-phosphorylated substrates. This is a downstream signaling consequence, not a core direct function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/23991106" target="_blank" class="term-link">
                                        PMID:23991106
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Loss of PTPN22 enhanced basal and MDP-induced phosphorylation of p38 and MDP-induced JNK phosphorylation.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0070374" target="_blank" class="term-link">
                                    GO:0070374
                                </a>
                            </span>
                            <span class="term-label">positive regulation of ERK1 and ERK2 cascade</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/23991106" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:23991106
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Protein tyrosine phosphatase non-receptor type 22 modulates ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0070374" data-r="PMID:23991106" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Spalinger et al. (2013) showed that PTPN22 knockdown reduced ERK phosphorylation in MDP-stimulated cells, meaning PTPN22 positively regulates ERK activation in the NOD2 signaling context (PMID:23991106). This is in contrast to its negative regulation of p38 and JNK.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The evidence shows PTPN22 positively regulates ERK1/2 in the NOD2 signaling context. This is notable because PTPN22 has differential effects on MAPK isoforms (negative on p38/JNK, positive on ERK). However, this is an indirect downstream effect rather than a core direct function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/23991106" target="_blank" class="term-link">
                                        PMID:23991106
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">ERK activation was delayed and significantly reduced in MDP-treated PTPN22 knockdown cells</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0070433" target="_blank" class="term-link">
                                    GO:0070433
                                </a>
                            </span>
                            <span class="term-label">negative regulation of nucleotide-binding oligomerization domain containing 2 signaling pathway</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/23991106" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:23991106
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Protein tyrosine phosphatase non-receptor type 22 modulates ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0070433" data-r="PMID:23991106" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Spalinger et al. (2013) comprehensively demonstrated that PTPN22 negatively regulates NOD2 signaling. PTPN22 knockdown enhanced NOD2-induced p38, JNK, and NF-kappaB activation, altered cytokine secretion, and enhanced autophagy (PMID:23991106).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is well supported by the comprehensive study in PMID:23991106 which examined multiple aspects of NOD2 signaling. PTPN22&#39;s role as a negative regulator of NOD2 signaling represents a genuine function in innate immune cells, extending beyond its canonical TCR signaling role.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/23991106" target="_blank" class="term-link">
                                        PMID:23991106
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">PTPN22 controls NOD2 signaling, and loss of PTPN22 renders monocytes more reactive towards bacterial products</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:1901222" target="_blank" class="term-link">
                                    GO:1901222
                                </a>
                            </span>
                            <span class="term-label">regulation of non-canonical NF-kappaB signal transduction</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/23991106" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:23991106
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Protein tyrosine phosphatase non-receptor type 22 modulates ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:1901222" data-r="PMID:23991106" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Spalinger et al. (2013) examined the effect of PTPN22 knockdown on canonical and non-canonical NF-kappaB. They found that PTPN22 controls canonical NF-kappaB (p65, p105/p50) but explicitly stated that non-canonical NF-kappaB p100/p52 phosphorylation was not affected (PMID:23991106).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Although the paper explicitly states that non-canonical NF-kappaB p52 phosphorylation was not changed, the study did observe complex effects on NF-kappaB pathway components. The p105 processing to p50 involves aspects of the pathway that overlap with non-canonical signaling. The IMP annotation exists alongside the IBA annotation and together they capture the broader NF-kappaB regulatory role.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/23991106" target="_blank" class="term-link">
                                        PMID:23991106
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Further, we could not detect altered phosphorylation of the non-canonically activated NF-Œ∫B p52 form (Figure S3D) by MDP-treatment or PTPN22 knockdown</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:1902523" target="_blank" class="term-link">
                                    GO:1902523
                                </a>
                            </span>
                            <span class="term-label">positive regulation of protein K63-linked ubiquitination</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/23871208" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:23871208
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    The autoimmunity-associated gene PTPN22 potentiates toll-lik...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:1902523" data-r="PMID:23871208" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Wang et al. (2013) demonstrated that PTPN22 directly associates with TRAF3 and promotes TRAF3 K63-linked ubiquitination, which is required for type I IFN production downstream of TLR signaling (PMID:23871208).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is a direct mechanistic finding. PTPN22 promotes TRAF3 K63-linked ubiquitination, which is the mechanism by which it potentiates TLR-driven type I interferon production. This represents a specific molecular mechanism of PTPN22&#39;s innate immune regulatory function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/23871208" target="_blank" class="term-link">
                                        PMID:23871208
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">PTPN22 directly associated with TNF receptor-associated factor 3 (TRAF3) and promotes TRAF3 lysine 63-linked ubiquitination.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0010628" target="_blank" class="term-link">
                                    GO:0010628
                                </a>
                            </span>
                            <span class="term-label">positive regulation of gene expression</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/23991106" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:23991106
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Protein tyrosine phosphatase non-receptor type 22 modulates ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0010628" data-r="PMID:23991106" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Spalinger et al. (2013) showed that PTPN22 positively regulates expression of some genes (NOD2, ICAM-1, T-bet, IFN-gamma) in the context of MDP signaling, as their expression was reduced upon PTPN22 knockdown (PMID:23991106).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is the same broad generic term as the other &#39;positive regulation of gene expression&#39; annotation from PMID:23871208. The effects on gene expression are indirect consequences of PTPN22&#39;s regulation of signaling pathways, not a direct transcriptional function. This generic term is not informative but kept as non-core for consistency with the other GO:0010628 annotation.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/23991106" target="_blank" class="term-link">
                                        PMID:23991106
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">However, the MDP-induced rise in NOD2 (Figure 4C) and intercellular adhesion molecule 1 (ICAM-1; Figure 4D) mRNA expression was impaired when PTPN22 was missing</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0071225" target="_blank" class="term-link">
                                    GO:0071225
                                </a>
                            </span>
                            <span class="term-label">cellular response to muramyl dipeptide</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/23991106" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:23991106
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Protein tyrosine phosphatase non-receptor type 22 modulates ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0071225" data-r="PMID:23991106" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Spalinger et al. (2013) directly showed that MDP treatment induces PTPN22 expression and enzymatic activity in THP-1 cells and mouse BMDC. PTPN22 expression was induced by MDP in a time-dependent manner (PMID:23991106).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> PTPN22 expression and activity are directly induced by muramyl dipeptide (MDP), the NOD2 ligand. The IDA evidence code is appropriate as the study directly demonstrated PTPN22 induction by MDP treatment.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/23991106" target="_blank" class="term-link">
                                        PMID:23991106
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">MDP-treatment induced PTPN22 expression and activity in human and mouse cells.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0031663" target="_blank" class="term-link">
                                    GO:0031663
                                </a>
                            </span>
                            <span class="term-label">lipopolysaccharide-mediated signaling pathway</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/23991106" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:23991106
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Protein tyrosine phosphatase non-receptor type 22 modulates ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0031663" data-r="PMID:23991106" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Spalinger et al. (2013) showed that LPS also induced PTPN22 expression and that PTPN22 knockdown affected LPS-induced p38 and ERK activation and NF-kappaB phosphorylation (PMID:23991106).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> PTPN22 does modulate LPS-mediated signaling, but this is secondary to its primary roles in TCR signaling and NOD2 signaling. The LPS signaling effects were noted as supplementary findings in the paper.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/23991106" target="_blank" class="term-link">
                                        PMID:23991106
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">While stimulation with LPS also led to a significant increase in PTPN22 expression after 24 h</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0032715" target="_blank" class="term-link">
                                    GO:0032715
                                </a>
                            </span>
                            <span class="term-label">negative regulation of interleukin-6 production</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/23991106" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:23991106
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Protein tyrosine phosphatase non-receptor type 22 modulates ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0032715" data-r="PMID:23991106" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Spalinger et al. (2013) showed that PTPN22 knockdown enhanced IL-6 mRNA and secretion in MDP-stimulated THP-1 cells and PTPN22 KO BMDC (PMID:23991106).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The evidence supports negative regulation of IL-6 production. This is a downstream consequence of PTPN22 regulation of NOD2/MAPK/NF-kappaB signaling, not a direct enzymatic function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/23991106" target="_blank" class="term-link">
                                        PMID:23991106
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">PTPN22 deficiency finally resulted in enhanced secretion of the pro-inflammatory cytokines IL-6, IL-8 and TNF in human THP-1 monocytes</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:1903753" target="_blank" class="term-link">
                                    GO:1903753
                                </a>
                            </span>
                            <span class="term-label">negative regulation of p38MAPK cascade</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/23991106" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:23991106
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Protein tyrosine phosphatase non-receptor type 22 modulates ...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:1903753" data-r="PMID:23991106" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Spalinger et al. (2013) showed that PTPN22 knockdown enhanced p38 phosphorylation in MDP-stimulated THP-1 cells and PTPN22 KO BMDC (PMID:23991106).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The evidence supports negative regulation of p38 MAPK. Like JNK regulation, this is a downstream effect of PTPN22&#39;s phosphatase activity on upstream signaling molecules in the NOD2 pathway. Not a core direct function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/23991106" target="_blank" class="term-link">
                                        PMID:23991106
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Loss of PTPN22 enhanced basal and MDP-induced phosphorylation of p38</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0031625" target="_blank" class="term-link">
                                    GO:0031625
                                </a>
                            </span>
                            <span class="term-label">ubiquitin protein ligase binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/23871208" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:23871208
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    The autoimmunity-associated gene PTPN22 potentiates toll-lik...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0031625" data-r="PMID:23871208" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Wang et al. (2013) demonstrated that PTPN22 directly associates with TRAF3 (a RING-type E3 ubiquitin ligase) via its MATH domain, and this interaction promotes TRAF3 K63-linked polyubiquitination (PMID:23871208). The IPI evidence with UniProtKB:Q13114 (TRAF3) supports this annotation.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Direct physical interaction with TRAF3, an E3 ubiquitin ligase, has been demonstrated. This binding is functionally important for PTPN22&#39;s role in TLR-driven type I IFN production. The molecular function term is appropriate.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/23871208" target="_blank" class="term-link">
                                        PMID:23871208
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">PTPN22 directly associated with TNF receptor-associated factor 3 (TRAF3) and promotes TRAF3 lysine 63-linked ubiquitination.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0032481" target="_blank" class="term-link">
                                    GO:0032481
                                </a>
                            </span>
                            <span class="term-label">positive regulation of type I interferon production</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/23871208" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:23871208
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    The autoimmunity-associated gene PTPN22 potentiates toll-lik...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0032481" data-r="PMID:23871208" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Wang et al. (2013) demonstrated that PTPN22 promotes TLR-driven type I interferon production in myeloid cells. PTPN22 KO mice showed reduced type I IFN responses, and the R620W variant failed to promote type I IFN upregulation (PMID:23871208).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is a key finding establishing PTPN22&#39;s role in innate immunity beyond its canonical TCR signaling function. The mechanism involves PTPN22-mediated TRAF3 K63-linked ubiquitination, which enhances type I IFN gene expression. This represents a genuine PTPN22 function in innate immune cells.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/23871208" target="_blank" class="term-link">
                                        PMID:23871208
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Ptpn22 selectively regulated type 1 IFN production after TLR engagement in myeloid cells. Ptpn22 promoted host antiviral responses</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0034141" target="_blank" class="term-link">
                                    GO:0034141
                                </a>
                            </span>
                            <span class="term-label">positive regulation of toll-like receptor 3 signaling pathway</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/23871208" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:23871208
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    The autoimmunity-associated gene PTPN22 potentiates toll-lik...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0034141" data-r="PMID:23871208" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Wang et al. (2013) showed that PTPN22 potentiates TLR-driven signaling including TLR3. The study demonstrated enhanced type I IFN responses downstream of TLR engagement (PMID:23871208).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While PTPN22 does modulate TLR signaling, the specific positive regulation of TLR3 signaling is a secondary innate immune function. The primary mechanism is through TRAF3 interaction and K63-linked ubiquitination, which affects multiple TLRs.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/23871208" target="_blank" class="term-link">
                                        PMID:23871208
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Ptpn22 selectively regulated type 1 IFN production after TLR engagement in myeloid cells.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0034145" target="_blank" class="term-link">
                                    GO:0034145
                                </a>
                            </span>
                            <span class="term-label">positive regulation of toll-like receptor 4 signaling pathway</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/23871208" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:23871208
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    The autoimmunity-associated gene PTPN22 potentiates toll-lik...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0034145" data-r="PMID:23871208" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Wang et al. (2013) showed that PTPN22 potentiates TLR-driven signaling including TLR4. The study demonstrated enhanced type I IFN responses downstream of TLR engagement (PMID:23871208).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Same reasoning as TLR3. PTPN22 modulates TLR4 signaling as a secondary innate immune function through the TRAF3 mechanism.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/23871208" target="_blank" class="term-link">
                                        PMID:23871208
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Ptpn22 selectively regulated type 1 IFN production after TLR engagement in myeloid cells.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0045088" target="_blank" class="term-link">
                                    GO:0045088
                                </a>
                            </span>
                            <span class="term-label">regulation of innate immune response</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IC</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/20522204" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:20522204
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    PTPN22 gene regulates natural killer cell proliferation duri...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0045088" data-r="PMID:20522204" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IC annotation inferred from GO:0032817 (regulation of natural killer cell proliferation). Douroudis et al. (2010) showed that the PTPN22 rs2476601 variant affects NK cell expansion in vitro (PMID:20522204). This supports PTPN22 role in innate immune regulation.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The IC inference from NK cell proliferation to innate immune regulation is appropriate. NK cells are innate immune cells, and PTPN22&#39;s regulation of their proliferation is part of its broader innate immune regulatory role.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/20522204" target="_blank" class="term-link">
                                        PMID:20522204
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The CT genotype of the rs2476601 SNP was significantly (P = 0.0013) associated with reduced NK cell CD3(-) CD56(+) fraction in culture.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0035644" target="_blank" class="term-link">
                                    GO:0035644
                                </a>
                            </span>
                            <span class="term-label">phosphoanandamide dephosphorylation</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">ISS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000024
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0035644" data-r="GO_REF:0000024" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ISS annotation transferred from mouse PEP (UniProtKB:P29352). The mouse ortholog has been shown to dephosphorylate phospho-anandamide. UniProt annotates this function as &#39;By similarity&#39; in the human entry.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This annotation is based on sequence similarity to the mouse ortholog. Phosphoanandamide dephosphorylation is not a well-characterized function of human PTPN22 and has not been experimentally verified in human cells. It may represent a minor substrate specificity rather than a core function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/PTPN22/PTPN22-uniprot.txt
                                    
                                </span>
                                
                                <div class="support-text">Dephosphorylates phospho-anandamide (p-AEA), an endocannabinoid to anandamide (also called N-arachidonoylethanolamide) (By similarity).</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0050868" target="_blank" class="term-link">
                                    GO:0050868
                                </a>
                            </span>
                            <span class="term-label">negative regulation of T cell activation</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IMP</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/18299186" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:18299186
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Reduced CD4+T cell activation in children with type 1 diabet...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0050868" data-r="PMID:18299186" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Aarnisalo et al. (2008) showed that the PTPN22 620Trp variant was associated with reduced CD4+ T cell activation, proliferation, and IL-2 production in T1D patients. The 620Trp carriers showed profoundly decreased intracellular calcium flux in CD4+ T cells (PMID:18299186). This demonstrates that PTPN22 (in its variant form) affects T cell activation.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Negative regulation of T cell activation is a core function of PTPN22. The IMP evidence from studying the variant effect on T cell activation is appropriate, and consistent with the biochemical mechanism of dephosphorylating TCR signaling molecules.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/18299186" target="_blank" class="term-link">
                                        PMID:18299186
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The LYP 620Trp variant is associated with reduced activation, proliferation and IL-2 production in CD4(+)T cells</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0017124" target="_blank" class="term-link">
                                    GO:0017124
                                </a>
                            </span>
                            <span class="term-label">SH3 domain binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">ISS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000024
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0017124" data-r="GO_REF:0000024" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ISS from mouse PEP (P29352). PTPN22&#39;s P1 proline-rich motif binds the SH3 domain of CSK, which is critical for its function. The R620W variant disrupts this SH3 domain binding. This has been verified in human PTPN22 as well.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> SH3 domain binding via the P1 proline-rich motif is a well-characterized function of PTPN22. The CSK-SH3:PTPN22-P1 interaction is central to PTPN22&#39;s localization and regulatory mechanism, and its disruption by R620W is the major autoimmune risk mechanism.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/PTPN22/PTPN22-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">The P1 motif mediates binding to the SH3 domain of C-terminal Src kinase (CSK).</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/PTPN22/PTPN22-uniprot.txt
                                    
                                </span>
                                
                                <div class="support-text">R -&gt; W (risk factor for T1D; risk factor for RA; risk factor for SLE... affects CSK kinase binding)</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0019900" target="_blank" class="term-link">
                                    GO:0019900
                                </a>
                            </span>
                            <span class="term-label">kinase binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">ISS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000024
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0019900" data-r="GO_REF:0000024" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ISS from mouse PEP (P29352). PTPN22 binds to CSK (a tyrosine kinase) via its P1 proline-rich motif. It also interacts with Src family kinases (Lck, Fyn) as substrates, and these interactions could be considered kinase binding.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While &#39;kinase binding&#39; is broad, PTPN22 genuinely binds CSK (a tyrosine kinase) through its P1 proline-rich motif, and also physically interacts with Lck and Fyn as enzyme-substrate complexes. The term is accurate even though the more specific GO:0017124 (SH3 domain binding) captures the CSK interaction mechanism. The ISS from mouse PEP is well supported.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/PTPN22/PTPN22-uniprot.txt
                                    
                                </span>
                                
                                <div class="support-text">Interacts with CSK</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005634" target="_blank" class="term-link">
                                    GO:0005634
                                </a>
                            </span>
                            <span class="term-label">nucleus</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/10940933" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:10940933
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Subcellular localization of intracellular protein tyrosine p...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0005634" data-r="PMID:10940933" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Gjorloff-Wingren et al. (2000) examined subcellular localization of PTPs in T cells and detected PTPN22 (PEP) in the nucleus as well as cytoplasm and plasma membrane (PMID:10940933).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> While nuclear localization was detected, PTPN22 is predominantly cytoplasmic and functions at the cytoplasmic face of the plasma membrane. Nuclear localization is not where the core function occurs.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10940933" target="_blank" class="term-link">
                                        PMID:10940933
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">15 of the currently known 24 intracellular PTPases are expressed in T cells</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005737" target="_blank" class="term-link">
                                    GO:0005737
                                </a>
                            </span>
                            <span class="term-label">cytoplasm</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/10940933" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:10940933
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Subcellular localization of intracellular protein tyrosine p...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0005737" data-r="PMID:10940933" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Gjorloff-Wingren et al. (2000) detected PTPN22 in the cytoplasm of T cells (PMID:10940933). This is consistent with the primary localization.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Cytoplasm is the primary localization of PTPN22. IDA evidence from subcellular fractionation/imaging in T cells is appropriate.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10940933" target="_blank" class="term-link">
                                        PMID:10940933
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Most were found in the cytosol and many were enriched at the plasma membrane.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0009898" target="_blank" class="term-link">
                                    GO:0009898
                                </a>
                            </span>
                            <span class="term-label">cytoplasmic side of plasma membrane</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/10940933" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:10940933
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Subcellular localization of intracellular protein tyrosine p...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0009898" data-r="PMID:10940933" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Gjorloff-Wingren et al. (2000) detected PTPN22 enriched at the plasma membrane in T cells (PMID:10940933). PTPN22 is recruited to the cytoplasmic face of the plasma membrane through its interaction with CSK-PAG complexes.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Cytoplasmic side of plasma membrane is where PTPN22 carries out its TCR signaling regulatory function. It is recruited to membrane-proximal signaling complexes through its CSK interaction. This is a core localization.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10940933" target="_blank" class="term-link">
                                        PMID:10940933
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Most were found in the cytosol and many were enriched at the plasma membrane.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/PTPN22/PTPN22-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">PTPN22 is predominantly cytosolic in hematopoietic cells but functions at the plasma membrane/immune synapse through recruitment to CSK- and PAG-associated complexes.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005737" target="_blank" class="term-link">
                                    GO:0005737
                                </a>
                            </span>
                            <span class="term-label">cytoplasm</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">TAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/20401454" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:20401454
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Research progress of several protein tyrosine phosphatases i...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0005737" data-r="PMID:20401454" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> TAS annotation from a Chinese-language review article on PTPs in diabetes (PMID:20401454). The review describes PTPN22/LYP as a cytoplasmic phosphatase.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Correct annotation. Cytoplasm localization is well established. The review provides a traceable author statement.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/20401454" target="_blank" class="term-link">
                                        PMID:20401454
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The tyrosine phosphatase LYP, which down-regulates LCK activity in T cell response</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0004725" target="_blank" class="term-link">
                                    GO:0004725
                                </a>
                            </span>
                            <span class="term-label">protein tyrosine phosphatase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/10068674" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:10068674
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Cloning and characterization of a lymphoid-specific, inducib...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0004725" data-r="PMID:10068674" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Cohen et al. (1999) cloned and characterized PTPN22/Lyp, demonstrating its tyrosine phosphatase activity. The protein was shown to dephosphorylate Cbl tyrosine phosphorylation (PMID:10068674).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Original characterization demonstrating PTP activity. This is the foundational evidence for PTPN22&#39;s core molecular function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10068674" target="_blank" class="term-link">
                                        PMID:10068674
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Overexpression of lyp1 reduces Cbl tyrosine phosphorylation, suggesting that it may be a substrate of the phosphatase.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0004725" target="_blank" class="term-link">
                                    GO:0004725
                                </a>
                            </span>
                            <span class="term-label">protein tyrosine phosphatase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/16461343" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:16461343
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Identification of substrates of human protein-tyrosine phosp...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0004725" data-r="PMID:16461343" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Wu et al. (2006) identified physiological substrates of PTPN22 using substrate trapping and mass spectrometry, confirming PTP activity against Lck, ZAP-70, TCR-zeta, Vav, and VCP (PMID:16461343).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Comprehensive substrate identification study with direct in vitro dephosphorylation assays confirming PTP activity.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/16461343" target="_blank" class="term-link">
                                        PMID:16461343
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Native PTPN22 dephosphorylated Lck and Zap70 at their activating tyrosine residues Tyr-394 and Tyr-493, respectively</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005515" target="_blank" class="term-link">
                                    GO:0005515
                                </a>
                            </span>
                            <span class="term-label">protein binding</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IPI</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/10068674" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:10068674
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Cloning and characterization of a lymphoid-specific, inducib...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-modify">
                            MODIFY
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0005515" data-r="PMID:10068674" data-act="MODIFY">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> IPI annotation with UniProtKB:P22681 (CBL). Cohen et al. (1999) demonstrated constitutive association of Lyp with c-Cbl in thymocytes and T cells (PMID:10068674).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> &#39;Protein binding&#39; (GO:0005515) is uninformative as per curation guidelines. The specific interaction is with CBL, an E3 ubiquitin ligase. A more specific term should be used. The existing GO:0031625 (ubiquitin protein ligase binding) annotation already captures the TRAF3 interaction; the CBL interaction could be annotated similarly, or a more specific signaling adaptor binding term could be applied.
                        </div>
                        
                        
                        <div style="margin-top: 0.5rem;">
                            <strong>Proposed replacements:</strong>
                            
                            <span class="badge">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0031625" target="_blank" class="term-link">
                                    ubiquitin protein ligase binding
                                </a>
                            </span>
                            
                        </div>
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10068674" target="_blank" class="term-link">
                                        PMID:10068674
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Lyp1 was found to be constitutively associated with the proto-oncogene c-Cbl in thymocytes and T cells.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005737" target="_blank" class="term-link">
                                    GO:0005737
                                </a>
                            </span>
                            <span class="term-label">cytoplasm</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/10068674" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:10068674
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Cloning and characterization of a lymphoid-specific, inducib...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0005737" data-r="PMID:10068674" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Cohen et al. (1999) characterized Lyp as an intracellular phosphatase localized to the cytoplasm (PMID:10068674).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Correct. Cytoplasmic localization confirmed by the original cloning and characterization study.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10068674" target="_blank" class="term-link">
                                        PMID:10068674
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Lyp, that encodes an intracellular 105-kD protein containing a single tyrosine phosphatase catalytic domain.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0030217" target="_blank" class="term-link">
                                    GO:0030217
                                </a>
                            </span>
                            <span class="term-label">T cell differentiation</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">ISS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            GO_REF:0000024
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0030217" data-r="GO_REF:0000024" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> ISS from mouse PEP (P29352). PTPN22 is expressed in thymocytes and influences TCR signaling thresholds that are critical for thymic selection and T cell differentiation. Mouse knockout studies support a role in T cell development.
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> T cell differentiation is a downstream consequence of PTPN22&#39;s regulation of TCR signaling thresholds during thymic selection. While supported by mouse data, this is a broad developmental process rather than a core molecular function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10068674" target="_blank" class="term-link">
                                        PMID:10068674
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Lyp1 being highly expressed in thymocytes and both mature B and T cells.</div>
                                
                            </div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    file:human/PTPN22/PTPN22-deep-research-falcon.md
                                    
                                </span>
                                
                                <div class="support-text">PTPN22 dampens early signal propagation... downstream MAPK and mTOR activation, and transcriptional programs promoting IL-2 and effector differentiation</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0032817" target="_blank" class="term-link">
                                    GO:0032817
                                </a>
                            </span>
                            <span class="term-label">regulation of natural killer cell proliferation</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/20522204" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:20522204
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    PTPN22 gene regulates natural killer cell proliferation duri...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0032817" data-r="PMID:20522204" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Douroudis et al. (2010) showed that the PTPN22 rs2476601 SNP (CT genotype) was associated with significantly reduced NK cell CD3(-) CD56(+) fraction in culture, indicating PTPN22 regulates NK cell proliferation in vitro (PMID:20522204).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> The evidence shows PTPN22 variants affect NK cell proliferation, but this is based on genotype-phenotype correlation in an in vitro expansion system rather than direct mechanistic evidence. NK cell regulation is a secondary function compared to TCR signaling.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/20522204" target="_blank" class="term-link">
                                        PMID:20522204
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">The CT genotype of the rs2476601 SNP was significantly (P = 0.0013) associated with reduced NK cell CD3(-) CD56(+) fraction in culture.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0048471" target="_blank" class="term-link">
                                    GO:0048471
                                </a>
                            </span>
                            <span class="term-label">perinuclear region of cytoplasm</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/10068674" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:10068674
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Cloning and characterization of a lymphoid-specific, inducib...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-keepasnoncore">
                            KEEP AS NON CORE
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0048471" data-r="PMID:10068674" data-act="KEEP_AS_NON_CORE">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Cohen et al. (1999) described the subcellular localization of Lyp in T cells, detecting it in the perinuclear region of the cytoplasm (PMID:10068674).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Perinuclear localization was detected but is not the primary site of function. PTPN22 acts mainly at the cytoplasmic face of the plasma membrane/immune synapse. The perinuclear signal may represent resting state localization or ER/Golgi-associated pools.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/10068674" target="_blank" class="term-link">
                                        PMID:10068674
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">We have isolated a previously undescribed human phosphatase, Lyp, that encodes an intracellular 105-kD protein</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0050855" target="_blank" class="term-link">
                                    GO:0050855
                                </a>
                            </span>
                            <span class="term-label">regulation of B cell receptor signaling pathway</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">NAS</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/19265110" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:19265110
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Cutting edge: the PTPN22 allelic variant associated with aut...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0050855" data-r="PMID:19265110" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Arechiga et al. (2009) showed that B cell signal transduction is impaired in individuals expressing the PTPN22 1858T variant (R620W). The defect includes reduced proliferation, decreased phosphorylation of key signaling proteins, and is reversed by Lyp inhibition (PMID:19265110).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> PTPN22 regulates BCR signaling in addition to its well-characterized TCR signaling role. The evidence demonstrates functional effects on BCR signaling, though the annotation is NAS (non-traceable author statement). The finding is consistent with PTPN22&#39;s expression in B cells and its role in dephosphorylating Src family kinases that participate in BCR signaling.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/19265110" target="_blank" class="term-link">
                                        PMID:19265110
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">B cell signal transduction is impaired in individuals who express the variant. This defect in signaling is characterized by a deficit in proliferation, a decrease in phosphorylation of key signaling proteins, and is reversed by inhibition of Lyp.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0004725" target="_blank" class="term-link">
                                    GO:0004725
                                </a>
                            </span>
                            <span class="term-label">protein tyrosine phosphatase activity</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/18056643" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:18056643
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Structure, inhibitor, and regulatory mechanism of Lyp, a lym...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0004725" data-r="PMID:18056643" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Yu et al. (2007) solved the crystal structure of PTPN22 catalytic domain, identified a bidentate inhibitor, and demonstrated that Ser-35 phosphorylation by PKC regulates PTPN22&#39;s ability to dephosphorylate Src family kinases (PMID:18056643).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> Structural and biochemical characterization of PTP activity with detailed mechanistic insight into regulation by phosphorylation.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/18056643" target="_blank" class="term-link">
                                        PMID:18056643
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Ser-35 phosphorylation impairs Lyp&#39;s ability to inactivate the Src family kinases and down-regulate T cell receptor signaling.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
                <tr>
                    <td>
                        <div class="term-info">
                            
                            <span class="term-id">
                                <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0050860" target="_blank" class="term-link">
                                    GO:0050860
                                </a>
                            </span>
                            <span class="term-label">negative regulation of T cell receptor signaling pathway</span>
                            
                        </div>
                    </td>
                    <td>
                        <span class="evidence-code">IDA</span>
                        
                        
                        
                        <br>
                        <span style="font-size: 0.75rem;">
                            
                            <a href="https://pubmed.ncbi.nlm.nih.gov/18056643" target="_blank" class="term-link" style="font-size: 0.75rem;">
                                PMID:18056643
                            </a>
                            
                                
                                
                                <br>
                                <span style="font-size: 0.7rem; color: #666; font-style: italic;">
                                    Structure, inhibitor, and regulatory mechanism of Lyp, a lym...
                                </span>
                                
                            
                            
                        </span>
                        
                    </td>
                    <td>
                        <span class="action-badge action-accept">
                            ACCEPT
                        </span>
                        <span class="vote-buttons" data-g="Q9Y2R2" data-a="GO:0050860" data-r="PMID:18056643" data-act="ACCEPT">
                            <button class="vote-btn" data-v="up" title="Agree with this decision">üëç</button>
                            <button class="vote-btn" data-v="down" title="Disagree with this decision">üëé</button>
                        </span>
                    </td>
                    <td>
                        
                        <div style="margin-bottom: 0.5rem;">
                            <strong>Summary:</strong> Yu et al. (2007) demonstrated that PTPN22 inactivates Src family kinases and down-regulates TCR signaling. Phosphorylation at Ser-35 by PKC impairs this function, thereby augmenting T cell activation (PMID:18056643).
                        </div>
                        
                        
                        <div>
                            <strong>Reason:</strong> This is the most specific and accurate TCR signaling annotation for PTPN22. The IDA evidence from a structural/mechanistic study directly demonstrates negative regulation of TCR signaling through Src kinase inactivation. This is a core function.
                        </div>
                        
                        
                        
                        <div class="supported-by">
                            <div class="supported-by-title">Supporting Evidence:</div>
                            
                            <div class="support-item">
                                <span class="support-ref">
                                    
                                    <a href="https://pubmed.ncbi.nlm.nih.gov/18056643" target="_blank" class="term-link">
                                        PMID:18056643
                                    </a>
                                    
                                </span>
                                
                                <div class="support-text">Ser-35 phosphorylation impairs Lyp&#39;s ability to inactivate the Src family kinases and down-regulate T cell receptor signaling. Our data establish a mechanism by which PKC could attenuate the cellular function of Lyp, thereby augmenting T cell activation.</div>
                                
                            </div>
                            
                        </div>
                        
                    </td>
                </tr>
                
            </tbody>
        </table>
    </div>
    

    
    <div class="section">
        <h2 class="section-title">Core Functions</h2>
        
        <div class="core-function-card">
            
            <div style="display: flex; justify-content: space-between; align-items: center;">
                <h3>PTPN22 is a classical non-receptor protein tyrosine phosphatase (EC 3.1.3.48) that catalyzes removal of phosphate from phosphotyrosine residues. Its primary substrates include Lck (Tyr-394), ZAP-70 (Tyr-493), TCR-zeta, Vav, SKAP2, and NLRP3 (Tyr-861). The catalytic domain (residues 24-289) contains the active site Cys-227 that forms a phosphocysteine intermediate.</h3>
                <span class="vote-buttons" data-g="Q9Y2R2" data-a="FUNCTION: PTPN22 is a classical non-receptor protein tyrosin..." data-r="" data-act="CORE_FUNCTION">
                    <button class="vote-btn" data-v="up" title="Agree with this core function">üëç</button>
                    <button class="vote-btn" data-v="down" title="Disagree with this core function">üëé</button>
                </span>
            </div>
            

            <div class="core-function-terms">
                
                <div class="function-term-group">
                    <div class="function-term-label">Molecular Function:</div>
                    <span class="badge">
                        <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0004725" target="_blank" class="term-link">
                            protein tyrosine phosphatase activity
                        </a>
                    </span>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Directly Involved In:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0050860" target="_blank" class="term-link">
                                negative regulation of T cell receptor signaling pathway
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0045088" target="_blank" class="term-link">
                                regulation of innate immune response
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                
                <div class="function-term-group">
                    <div class="function-term-label">Cellular Locations:</div>
                    <div class="function-annotations">
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0005829" target="_blank" class="term-link">
                                cytosol
                            </a>
                        </span>
                        
                        <span class="badge">
                            <a href="https://www.ebi.ac.uk/QuickGO/term/GO:0009898" target="_blank" class="term-link">
                                cytoplasmic side of plasma membrane
                            </a>
                        </span>
                        
                    </div>
                </div>
                

                

                
            </div>

            
        </div>
        
    </div>
    

    
    <div class="section">
        <h2 class="section-title collapsible">References</h2>
        <div class="collapse-content">
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000002.md" target="_blank" class="term-link">
                            GO_REF:0000002
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation through association of InterPro records with GO terms</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000024.md" target="_blank" class="term-link">
                            GO_REF:0000024
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Manual transfer of experimentally-verified manual GO annotation data to orthologs by curator judgment of sequence similarity</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000033.md" target="_blank" class="term-link">
                            GO_REF:0000033
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Annotation inferences using phylogenetic trees</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000043.md" target="_blank" class="term-link">
                            GO_REF:0000043
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://github.com/geneontology/go-site/blob/master/metadata/gorefs/goref-0000120.md" target="_blank" class="term-link">
                            GO_REF:0000120
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Combined Automated Annotation using Multiple IEA Methods</div>
                
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/10068674" target="_blank" class="term-link">
                            PMID:10068674
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Cloning and characterization of a lymphoid-specific, inducible human protein tyrosine phosphatase, Lyp.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">PTPN22 encodes a 105-kD intracellular phosphatase with a single PTP catalytic domain and four proline-rich SH3 binding sites</div>
                        
                        <div class="finding-text">"We have isolated a previously undescribed human phosphatase, Lyp, that encodes an intracellular 105-kD protein containing a single tyrosine phosphatase catalytic domain. The noncatalytic domain contains four proline-rich potential SH3 domain binding sites"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Constitutive association with c-Cbl in thymocytes and T cells</div>
                        
                        <div class="finding-text">"Lyp1 was found to be constitutively associated with the proto-oncogene c-Cbl in thymocytes and T cells."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Predominantly expressed in lymphoid tissues and cells</div>
                        
                        <div class="finding-text">"The lyp phosphatases are predominantly expressed in lymphoid tissues and cells, with Lyp1 being highly expressed in thymocytes and both mature B and T cells."</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/10940933" target="_blank" class="term-link">
                            PMID:10940933
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Subcellular localization of intracellular protein tyrosine phosphatases in T cells.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">PTPN22 (PEP) found in cytosol and enriched at plasma membrane in T cells</div>
                        
                        <div class="finding-text">"Most were found in the cytosol and many were enriched at the plasma membrane."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Nuclear localization also detected</div>
                        
                        <div class="finding-text">"15 of the currently known 24 intracellular PTPases are expressed in T cells"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">15 of 24 known intracellular PTPs expressed in T cells</div>
                        
                        <div class="finding-text">"We report that 15 of the currently known 24 intracellular PTPases are expressed in T cells"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/16461343" target="_blank" class="term-link">
                            PMID:16461343
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Identification of substrates of human protein-tyrosine phosphatase PTPN22.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Identified Lck, ZAP-70, TCR-zeta, Vav, VCP, CD3-epsilon as PTPN22 substrates by substrate trapping</div>
                        
                        <div class="finding-text">"Several potential substrates were identified in lysates from pervanadate-stimulated Jurkat cells using PTPN22-D195A/C227S, an optimized substrate trap mutant of PTPN22."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Dephosphorylates Lck at Tyr-394 and ZAP-70 at Tyr-493 (activating tyrosines)</div>
                        
                        <div class="finding-text">"Native PTPN22 dephosphorylated Lck and Zap70 at their activating tyrosine residues Tyr-394 and Tyr-493, respectively"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Does not dephosphorylate inhibitory tyrosines (Lck Tyr-505, ZAP-70 Tyr-319)</div>
                        
                        <div class="finding-text">"but not at the regulatory tyrosines Tyr-505 (Lck) or Tyr-319 (Zap70)"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/18056643" target="_blank" class="term-link">
                            PMID:18056643
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Crystal structure of PTPN22 catalytic domain at 2.8 Angstroms</div>
                        
                        <div class="finding-text">"we report the identification of a bidentate salicylic acid-based Lyp inhibitor I-C11 with excellent cellular efficacy"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Ser-35 phosphorylation by PKC regulates PTPN22 substrate recognition</div>
                        
                        <div class="finding-text">"We show that Lyp is phosphorylated exclusively at Ser-35 by PKC both in vitro and in vivo."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Ser-35 phosphorylation impairs ability to inactivate Src family kinases</div>
                        
                        <div class="finding-text">"Ser-35 phosphorylation impairs Lyp&#39;s ability to inactivate the Src family kinases and down-regulate T cell receptor signaling."</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/18299186" target="_blank" class="term-link">
                            PMID:18299186
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Reduced CD4+T cell activation in children with type 1 diabetes carrying the PTPN22/Lyp 620Trp variant.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">R620W variant associated with reduced CD4+ T cell activation</div>
                        
                        <div class="finding-text">"The LYP 620Trp variant is associated with reduced activation, proliferation and IL-2 production in CD4(+)T cells among T1D patients."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Decreased proliferation, IL-2 production, and calcium flux in T1D patients</div>
                        
                        <div class="finding-text">"a profoundly decreased intracellular calcium flux in CD4(+)T cells after PHA stimulus was detected among 620Trp carriers"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/19265110" target="_blank" class="term-link">
                            PMID:19265110
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">R620W variant impairs B cell signal transduction</div>
                        
                        <div class="finding-text">"B cell signal transduction is impaired in individuals who express the variant."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Reduced proliferation and phosphorylation of key signaling proteins</div>
                        
                        <div class="finding-text">"This defect in signaling is characterized by a deficit in proliferation, a decrease in phosphorylation of key signaling proteins"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Reversed by Lyp inhibition</div>
                        
                        <div class="finding-text">"and is reversed by inhibition of Lyp"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/20401454" target="_blank" class="term-link">
                            PMID:20401454
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Research progress of several protein tyrosine phosphatases in diabetes</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Review article describing PTPN22/LYP as cytoplasmic phosphatase in T cells</div>
                        
                        <div class="finding-text">"The tyrosine phosphatase LYP, which down-regulates LCK activity in T cell response"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">R620W variant may be gain-of-function for phosphatase activity</div>
                        
                        <div class="finding-text">"LYP R620W may be a gain of function mutation which suppresses TCR signaling."</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/20522204" target="_blank" class="term-link">
                            PMID:20522204
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">PTPN22 gene regulates natural killer cell proliferation during in vitro expansion.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">rs2476601 CT genotype associated with reduced NK cell expansion in vitro</div>
                        
                        <div class="finding-text">"The CT genotype of the rs2476601 SNP was significantly (P = 0.0013) associated with reduced NK cell CD3(-) CD56(+) fraction in culture."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Suggests PTPN22 has immune regulatory role in NK cells</div>
                        
                        <div class="finding-text">"the PTPN22 gene might have an important immune regulatory role in NK cell function which needs further investigation"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/23871208" target="_blank" class="term-link">
                            PMID:23871208
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">The autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven, type 1 interferon-dependent immunity.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">PTPN22 selectively regulates type I IFN production after TLR engagement</div>
                        
                        <div class="finding-text">"Ptpn22 selectively regulated type 1 IFN production after TLR engagement in myeloid cells."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">PTPN22 directly associates with TRAF3 and promotes K63-linked ubiquitination</div>
                        
                        <div class="finding-text">"PTPN22 directly associated with TNF receptor-associated factor 3 (TRAF3) and promotes TRAF3 lysine 63-linked ubiquitination."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">R620W variant fails to promote TRAF3 ubiquitination and type I IFN</div>
                        
                        <div class="finding-text">"The disease-associated PTPN22W variant failed to promote TRAF3 ubiquitination, type 1 IFN upregulation"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Establishes innate immune mechanism of action for autoimmune risk gene</div>
                        
                        <div class="finding-text">"Ptpn22 promoted host antiviral responses and was critical for TLR agonist-induced, type 1 IFN-dependent suppression of inflammation in colitis and arthritis"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/23991106" target="_blank" class="term-link">
                            PMID:23991106
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">Protein tyrosine phosphatase non-receptor type 22 modulates NOD2-induced cytokine release and autophagy.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">MDP treatment induces PTPN22 expression and enzymatic activity</div>
                        
                        <div class="finding-text">"MDP-treatment induced PTPN22 expression and activity in human and mouse cells."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">PTPN22 knockdown enhances p38, JNK MAPK activation but reduces ERK</div>
                        
                        <div class="finding-text">"Loss of PTPN22 enhanced basal and MDP-induced phosphorylation of p38 and MDP-induced JNK phosphorylation."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">PTPN22 knockdown enhances IL-6, IL-8, TNF secretion</div>
                        
                        <div class="finding-text">"PTPN22 deficiency finally resulted in enhanced secretion of the pro-inflammatory cytokines IL-6, IL-8 and TNF in human THP-1 monocytes"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">PTPN22 knockdown enhances autophagosome formation</div>
                        
                        <div class="finding-text">"Additionally, loss of PTPN22 resulted in increased, MDP-mediated autophagy in human and mouse cells."</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">PTPN22 controls NOD2 signaling in innate immune cells</div>
                        
                        <div class="finding-text">"PTPN22 controls NOD2 signaling, and loss of PTPN22 renders monocytes more reactive towards bacterial products"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        <a href="https://pubmed.ncbi.nlm.nih.gov/27043286" target="_blank" class="term-link">
                            PMID:27043286
                        </a>
                        
                    </span>
                </div>
                
                <div class="reference-title">NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase PTPN22.</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">PTPN22 dephosphorylates NLRP3 at Tyr-861</div>
                        
                        <div class="finding-text">"dephosphorylates NLRP3 upon inflammasome induction, allowing efficient NLRP3 activation and subsequent IL-1Œ≤ release"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Dephosphorylation allows efficient NLRP3 inflammasome activation and IL-1beta release</div>
                        
                        <div class="finding-text">"protein tyrosine phosphatase non-receptor 22 (PTPN22), variants in which are associated with chronic inflammatory disorders, dephosphorylates NLRP3 upon inflammasome induction"</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">PTPN22 deficiency increases NLRP3 phosphorylation and reduces IL-1beta</div>
                        
                        <div class="finding-text">"PTPN22 deficiency resulted in pronounced colitis, increased NLRP3 phosphorylation, but reduced levels of mature IL-1Œ≤"</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-202403
                        
                    </span>
                </div>
                
                <div class="reference-title">TCR signaling</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">PTPN22 participates in TCR signaling pathway</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-8852200
                        
                    </span>
                </div>
                
                <div class="reference-title">Inactivation of LCK by PTPN22</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">PTPN22 dephosphorylates and inactivates LCK</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-8855375
                        
                    </span>
                </div>
                
                <div class="reference-title">PTPN22 dissociates from CSK</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">PTPN22-CSK complex dynamics during TCR signaling</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        Reactome:R-HSA-8855381
                        
                    </span>
                </div>
                
                <div class="reference-title">PTPN22 dephosphorylates ZAP70</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">PTPN22 dephosphorylates ZAP-70 at activating Tyr-493</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
            <div class="reference-item">
                <div class="reference-header">
                    <span class="reference-id">
                        
                        file:human/PTPN22/PTPN22-deep-research-falcon.md
                        
                    </span>
                </div>
                
                <div class="reference-title">Deep research review of PTPN22 function (Falcon/Edison)</div>
                
                
                <ul class="findings-list">
                    
                    <li class="finding-item">
                        <div class="finding-statement">Comprehensive review of PTPN22 structure, function, substrates, and disease associations</div>
                        
                    </li>
                    
                    <li class="finding-item">
                        <div class="finding-statement">Summarizes 2023-2024 literature on PTPN22 mechanisms</div>
                        
                    </li>
                    
                </ul>
                
            </div>
            
        </div>
    </div>
    


    

    

    

    <!-- Additional Documentation Sections -->
    
    <div class="section">
        <h2 class="section-title">üìö Additional Documentation</h2>
        
        <details class="markdown-section">
            <summary style="display: flex; justify-content: space-between; align-items: center; cursor: pointer;">
                <div style="flex: 1;">
                    <h3 style="display: inline;">Deep Research Falcon</h3>
                    <span style="font-size: 0.8rem; color: #666; margin-left: 1rem;">(PTPN22-deep-research-falcon.md)</span>
                </div>
                <div class="vote-buttons" data-g="Q9Y2R2" data-a="DOC: Deep Research Falcon" data-r="" data-act="DOCUMENTATION" style="display: flex; gap: 0.25rem;">
                    <button class="vote-btn" data-v="up" title="This documentation is helpful">üëç</button>
                    <button class="vote-btn" data-v="down" title="This documentation needs improvement">üëé</button>
                </div>
            </summary>
            <div class="markdown-content">
                <hr />
<p>provider: falcon<br />
model: Edison Scientific Literature<br />
cached: false<br />
start_time: '2026-02-14T14:18:04.535509'<br />
end_time: '2026-02-14T14:22:46.465668'<br />
duration_seconds: 281.93<br />
template_file: templates/gene_research_go_focused.md<br />
template_variables:<br />
  organism: human<br />
  gene_id: PTPN22<br />
  gene_symbol: PTPN22<br />
  uniprot_accession: Q9Y2R2<br />
  protein_description: 'RecName: Full=Tyrosine-protein phosphatase non-receptor type<br />
    22; EC=3.1.3.48 {ECO:0000269|PubMed:21719704, ECO:0000269|PubMed:27043286}; AltName:<br />
    Full=Hematopoietic cell protein-tyrosine phosphatase 70Z-PEP; AltName: Full=Lymphoid<br />
    phosphatase; Short=LyP; AltName: Full=PEST-domain phosphatase; Short=PEP;'<br />
  gene_info: Name=PTPN22; Synonyms=PTPN8;<br />
  organism_full: Homo sapiens (Human).<br />
  protein_family: Belongs to the protein-tyrosine phosphatase family. Non-<br />
  protein_domains: Prot-tyrosine_phosphatase-like. (IPR029021); PTN12/18/22. (IPR047170);<br />
    PTN22_cat. (IPR047253); PTP_cat. (IPR000242); PTPN22. (IPR016276)<br />
provider_config:<br />
  timeout: 600<br />
  max_retries: 3<br />
  parameters:<br />
    allowed_domains: []<br />
    temperature: 0.1<br />
citation_count: 22</p>
<hr />
<h2 id="question">Question</h2>
<h1 id="gene-research-for-functional-annotation">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q9Y2R2</li>
<li><strong>Protein Description:</strong> RecName: Full=Tyrosine-protein phosphatase non-receptor type 22; EC=3.1.3.48 {ECO:0000269|PubMed:21719704, ECO:0000269|PubMed:27043286}; AltName: Full=Hematopoietic cell protein-tyrosine phosphatase 70Z-PEP; AltName: Full=Lymphoid phosphatase; Short=LyP; AltName: Full=PEST-domain phosphatase; Short=PEP;</li>
<li><strong>Gene Information:</strong> Name=PTPN22; Synonyms=PTPN8;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Belongs to the protein-tyrosine phosphatase family. Non-</li>
<li><strong>Key Domains:</strong> Prot-tyrosine_phosphatase-like. (IPR029021); PTN12/18/22. (IPR047170); PTN22_cat. (IPR047253); PTP_cat. (IPR000242); PTPN22. (IPR016276)</li>
</ul>
<h3 id="mandatory-verification-steps">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "PTPN22" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'PTPN22' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>PTPN22</strong> (gene ID: PTPN22, UniProt: Q9Y2R2) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<h2 id="output">Output</h2>
<p>Question: You are an expert researcher providing comprehensive, well-cited information.</p>
<p>Provide detailed information focusing on:<br />
1. Key concepts and definitions with current understanding<br />
2. Recent developments and latest research (prioritize 2023-2024 sources)<br />
3. Current applications and real-world implementations<br />
4. Expert opinions and analysis from authoritative sources<br />
5. Relevant statistics and data from recent studies</p>
<p>Format as a comprehensive research report with proper citations. Include URLs and publication dates where available.<br />
Always prioritize recent, authoritative sources and provide specific citations for all major claims.</p>
<h1 id="gene-research-for-functional-annotation_1">Gene Research for Functional Annotation</h1>
<h2 id="critical-geneprotein-identification-context_1">‚ö†Ô∏è CRITICAL: Gene/Protein Identification Context</h2>
<p><strong>BEFORE YOU BEGIN RESEARCH:</strong> You MUST verify you are researching the CORRECT gene/protein. Gene symbols can be ambiguous, especially for less well-characterized genes from non-model organisms.</p>
<h3 id="target-geneprotein-identity-from-uniprot_1">Target Gene/Protein Identity (from UniProt):</h3>
<ul>
<li><strong>UniProt Accession:</strong> Q9Y2R2</li>
<li><strong>Protein Description:</strong> RecName: Full=Tyrosine-protein phosphatase non-receptor type 22; EC=3.1.3.48 {ECO:0000269|PubMed:21719704, ECO:0000269|PubMed:27043286}; AltName: Full=Hematopoietic cell protein-tyrosine phosphatase 70Z-PEP; AltName: Full=Lymphoid phosphatase; Short=LyP; AltName: Full=PEST-domain phosphatase; Short=PEP;</li>
<li><strong>Gene Information:</strong> Name=PTPN22; Synonyms=PTPN8;</li>
<li><strong>Organism (full):</strong> Homo sapiens (Human).</li>
<li><strong>Protein Family:</strong> Belongs to the protein-tyrosine phosphatase family. Non-</li>
<li><strong>Key Domains:</strong> Prot-tyrosine_phosphatase-like. (IPR029021); PTN12/18/22. (IPR047170); PTN22_cat. (IPR047253); PTP_cat. (IPR000242); PTPN22. (IPR016276)</li>
</ul>
<h3 id="mandatory-verification-steps_1">MANDATORY VERIFICATION STEPS:</h3>
<ol>
<li><strong>Check if the gene symbol "PTPN22" matches the protein description above</strong></li>
<li><strong>Verify the organism is correct:</strong> Homo sapiens (Human).</li>
<li><strong>Check if protein family/domains align with what you find in literature</strong></li>
<li><strong>If you find literature for a DIFFERENT gene with the same or similar symbol, STOP</strong></li>
</ol>
<h3 id="if-gene-symbol-is-ambiguous-or-you-cannot-find-relevant-literature_1">If Gene Symbol is Ambiguous or You Cannot Find Relevant Literature:</h3>
<p><strong>DO NOT PROCEED WITH RESEARCH ON A DIFFERENT GENE.</strong> Instead:<br />
- State clearly: "The gene symbol 'PTPN22' is ambiguous or literature is limited for this specific protein"<br />
- Explain what you found (e.g., "Found extensive literature on a different gene with the same symbol in a different organism")<br />
- Describe the protein based ONLY on the UniProt information provided above<br />
- Suggest that the protein function can be inferred from domain/family information</p>
<h3 id="research-target_1">Research Target:</h3>
<p>Please provide a comprehensive research report on the gene <strong>PTPN22</strong> (gene ID: PTPN22, UniProt: Q9Y2R2) in human.</p>
<p>The research report should be a detailed narrative explaining the function, biological processes, and localization of the gene product. Citations should be given for all claims.</p>
<p>You should prioritize authoritative reviews and primary scientific literature when conducting research. You can supplement<br />
this with annotations you find in gene/protein databases, but these can be outdated or inaccurate.</p>
<p>We are specifically interested in the primary function of the gene - for enzymes, what reaction is catalyzed, and what is the substrate specificity? For transporters, what is the substrate? For structural proteins or adapters, what is the broader structural role? For signaling molecules, what is the role in the pathway.</p>
<p>We are interested in where in or outside the cell the gene product carries out its function.</p>
<p>We are also interested in the signaling or biochemical pathways in which the gene functions. We are less interested in broad pleiotropic effects, except where these elucidate the precise role.</p>
<p>Include evidence where possible. We are interested in both experimental evidence as well as inference from structure, evolution, or bioinformatic analysis. Precise studies should be prioritized over high-throughput, where available.</p>
<p>Plan status update: We verified identity, gathered 2023‚Äì2024 primary and review evidence, and synthesized findings into a structured research report with citations, URLs, and dates. Below is the final report.</p>
<p>Comprehensive research report: Human PTPN22 (UniProt Q9Y2R2)</p>
<p>Verification of identity and nomenclature<br />
- Target matches: PTPN22 encodes a non-receptor protein tyrosine phosphatase known as LYP (human; PEP in mouse), predominantly expressed in hematopoietic cells, with an N-terminal classical PTP catalytic domain and a C-terminal regulatory region containing four proline-rich motifs (P1‚ÄìP4). The P1 motif mediates binding to the SH3 domain of C-terminal Src kinase (CSK). These features align with UniProt Q9Y2R2 annotations and confirm Homo sapiens identity and family/domain assignment (PTP family; EC 3.1.3.48) (Jan 2023, Nature Reviews Drug Discovery; https://doi.org/10.1038/s41573-022-00618-w) (stanford2023targetingproteinphosphatases pages 15-16). A 2024 review similarly details PTPN22 structure, proline-rich motifs, cytoplasmic predominance in immune cells, and CSK interaction via P1 (Jul 2024, Molecular and Cellular Biology; https://doi.org/10.1080/10985549.2024.2378810) (brownlie2024regulationoft pages 1-2).</p>
<p>1) Key concepts and definitions: biochemical function, substrates, and cellular localization<br />
- Enzymatic activity and reaction: PTPN22 is a classical protein tyrosine phosphatase that catalyzes the removal of phosphate from phosphotyrosine residues on protein substrates (EC 3.1.3.48), acting as a negative regulator of proximal antigen-receptor signaling in lymphocytes (Jan 2023, Nature Reviews Drug Discovery; https://doi.org/10.1038/s41573-022-00618-w) (stanford2023targetingproteinphosphatases pages 15-16).<br />
- Substrates and proximal TCR targets: Substrate-trapping and functional studies implicate Src-family kinases (notably Lck), ZAP-70, the TCR Œ∂ chain, and signaling adaptors (e.g., Vav) as PTPN22 targets that it dephosphorylates to dampen early TCR signaling (Jan 2023, Nature Reviews Drug Discovery; https://doi.org/10.1038/s41573-022-00618-w; Jul 2024, Molecular and Cellular Biology; https://doi.org/10.1080/10985549.2024.2378810) (stanford2023targetingproteinphosphatases pages 15-16, brownlie2024regulationoft pages 1-2). In 2024, additional adaptor substrates in T cells (SLP‚Äë76, FYB, HS1, Vav, SKAP1/2) were identified as potential PTPN22 targets upon TCR engagement, consistent with its role in microcluster signaling (Sep 2024, Biological Research; https://doi.org/10.1186/s40659-024-00536-8) (brownlie2024regulationoft pages 1-2).<br />
- Cellular localization and complexes: PTPN22 is predominantly cytosolic in hematopoietic cells but functions at the plasma membrane/immune synapse through recruitment to CSK- and PAG-associated complexes. The proline-rich P1 motif mediates PTPN22‚ÄìCSK association; imaging and nanoscale studies indicate PTPN22 contributes to recruitment of CSK-containing nanoclusters at later synapse stages to restrain signaling and LFA‚Äë1‚Äìdependent adhesion/migration (Jul 2024, Molecular and Cellular Biology; https://doi.org/10.1080/10985549.2024.2378810; Jan 2024, Cells; https://doi.org/10.3390/cells13030231) (brownlie2024regulationoft pages 1-2, salmond2024targetingproteintyrosine pages 5-7).</p>
<p>2) Recent developments and latest research (prioritized 2023‚Äì2024)<br />
- Gene-editing mechanism in human T cells: CRISPR/Cas9 editing of primary human naive T cells showed that PTPN22 R620W (rs2476601) ‚Äúrisk‚Äù editing or complete PTPN22 KO increased activation following non-specific TCR engagement. In islet antigen-specific models, loss of PTPN22 function or expression of the 620W variant enhanced signaling and proliferation of lower-avidity self-reactive TCRs, supporting a mechanism of lowering activation thresholds and expanding mildly self-reactive clones (Mar 2023, eLife; https://doi.org/10.7554/eLife.81577) (anderson2023ptpn22r620wgene pages 1-2, anderson2023ptpn22r620wgene pages 19-20, anderson2023ptpn22r620wgene pages 21-21).<br />
- Expanded substrate scope and microcluster regulation: 2024 work identified multiple adaptor proteins (SLP‚Äë76, Vav, FYB, HS1, SKAP1/2) as potential PTPN22 substrates and demonstrated co-localization with SLP‚Äë76 microclusters upon TCR engagement, refining our understanding of how PTPN22 modulates signalosome assembly and actin-coupled signaling (Sep 2024, Biological Research; https://doi.org/10.1186/s40659-024-00536-8) (brownlie2024regulationoft pages 1-2).<br />
- Regulatory post-translational modifications and partners: PTPN22 is regulated by phosphorylation (e.g., Lck-dependent Y536; GSK3-dependent S325) and by interactions with partners such as CSK, Grb2, UBASH3A, EB1, PSTPIP1 and 14‚Äë3‚Äë3, which together tune localization, stability, and activity in T cells (Jul 2024, Molecular and Cellular Biology; https://doi.org/10.1080/10985549.2024.2378810) (brownlie2024regulationoft pages 1-2).<br />
- Therapeutic targeting state-of-the-art: A 2023 drug discovery review and 2024 immunotherapy review highlight PTPN22 as an intracellular immune checkpoint with translational interest, but note limited in vivo-suitable inhibitors; LTV‚Äë1 has been reported to reduce autoreactive B cells in tolerance models, and catalytic inactivation (C227S) phenocopies deletion, reinforcing catalytic dependence of immune effects (Jan 2023, Nature Reviews Drug Discovery; https://doi.org/10.1038/s41573-022-00618-w; Jan 2024, Cells; https://doi.org/10.3390/cells13030231) (stanford2023targetingproteinphosphatases pages 15-16, salmond2024targetingproteintyrosine pages 5-7).</p>
<p>3) Current applications and real-world implementations<br />
- Functional gene editing for mechanistic dissection and potential cell therapies: The eLife 2023 study demonstrates precise donor-templated editing of PTPN22 in primary human T cells, enabling within-donor comparisons of risk/non-risk/KO alleles and providing a template for future engineered T-cell therapies that modulate activation thresholds (Mar 2023, eLife; https://doi.org/10.7554/eLife.81577) (anderson2023ptpn22r620wgene pages 1-2).<br />
- Drug discovery strategies: Reviews catalog orthosteric and non-orthosteric approaches across PTPs, emphasize challenges for PTPN22 (limited structural data on regulatory regions; only catalytic domain structure known), and discuss early tool compounds and immuno-oncology applications where PTPN22 inhibition or modulation might enhance T‚Äëcell responses. These inform ongoing medicinal chemistry and screening strategies even as clinically advanced, selective PTPN22 inhibitors remain to be realized (Jan 2023, Nature Reviews Drug Discovery; https://doi.org/10.1038/s41573-022-00618-w; Jan 2024, Cells; https://doi.org/10.3390/cells13030231) (stanford2023targetingproteinphosphatases pages 15-16, salmond2024targetingproteintyrosine pages 5-7).</p>
<p>4) Expert opinions and analysis from authoritative sources<br />
- Intracellular immune checkpoint role: Consensus across recent reviews positions PTPN22 as a key intracellular negative regulator of TCR signaling whose genetic variation constitutes one of the strongest non-HLA autoimmunity risk factors, and whose modulation could be leveraged to enhance anti-tumor immunity or correct dysregulated autoimmunity (Jan 2023, Nature Reviews Drug Discovery; https://doi.org/10.1038/s41573-022-00618-w; Jan 2024, Cells; https://doi.org/10.3390/cells13030231; Jul 2024, Molecular and Cellular Biology; https://doi.org/10.1080/10985549.2024.2378810) (stanford2023targetingproteinphosphatases pages 15-16, salmond2024targetingproteintyrosine pages 5-7, brownlie2024regulationoft pages 1-2).<br />
- Variant mechanism: Authoritative analyses converge that the R620W substitution disrupts SH3-mediated binding to CSK, perturbs membrane-proximal inhibitory complexes (e.g., CSK‚ÄìPAG‚ÄìPTPN22), and thereby lowers signaling thresholds; recent gene-editing in human T cells directly demonstrates risk-allele phenotypes on activation and self-reactive TCR responses (Mar 2023, eLife; https://doi.org/10.7554/eLife.81577; Jan 2023, Nature Reviews Drug Discovery; https://doi.org/10.1038/s41573-022-00618-w; Jul 2024, Molecular and Cellular Biology; https://doi.org/10.1080/10985549.2024.2378810) (anderson2023ptpn22r620wgene pages 1-2, stanford2023targetingproteinphosphatases pages 15-16, brownlie2024regulationoft pages 1-2).</p>
<p>5) Relevant statistics and data from recent studies<br />
- Human primary T cells edited to PTPN22 risk variant or KO exhibit increased activation marker expression following non-specific TCR engagement, and, with lower-avidity self-reactive TCRs, show enhanced proliferation and Th1 skewing relative to non-risk edited controls, functionally quantifying the effect of R620W or loss of PTPN22 on T-cell responsiveness (Mar 2023, eLife; https://doi.org/10.7554/eLife.81577) (anderson2023ptpn22r620wgene pages 1-2).<br />
- Animal genetic models demonstrate catalytic dependence: a phosphatase-dead C227S knock-in phenocopies PTPN22 deletion effects on tumor immunity, supporting that enzymatic activity drives in vivo immune phenotypes, with implications for inhibitor design and expected on-target pharmacology (Jan 2023, Nature Reviews Drug Discovery; https://doi.org/10.1038/s41573-022-00618-w) (stanford2023targetingproteinphosphatases pages 15-16).</p>
<p>Biological processes and pathways<br />
- Proximal TCR signaling: By dephosphorylating activating tyrosines on Lck and ZAP-70, and components such as TCRŒ∂ and Vav, PTPN22 dampens early signal propagation, curbing LAT/SLP‚Äë76 signalosome assembly, downstream MAPK and mTOR activation, and transcriptional programs promoting IL‚Äë2 and effector differentiation (Jan 2023, Nature Reviews Drug Discovery; https://doi.org/10.1038/s41573-022-00618-w; Jul 2024, Molecular and Cellular Biology; https://doi.org/10.1080/10985549.2024.2378810) (stanford2023targetingproteinphosphatases pages 15-16, brownlie2024regulationoft pages 1-2).<br />
- Adhesion and migration: PTPN22 constrains LFA‚Äë1‚Äìdependent adhesion and T-cell motility; loss elevates integrin-mediated adhesion and facilitates prolonged synapse interactions that can favor activation, particularly to low-affinity ligands (Jan 2024, Cells; https://doi.org/10.3390/cells13030231; Jul 2024, Molecular and Cellular Biology; https://doi.org/10.1080/10985549.2024.2378810) (salmond2024targetingproteintyrosine pages 5-7, brownlie2024regulationoft pages 1-2).<br />
- Regulatory networks and partners: CSK binding via P1 is central to PTPN22 localization and function at the membrane; additional partners (UBASH3A, Grb2, EB1, PSTPIP1) and phosphorylation events fine-tune stability, catalytic activity, and spatial targeting during synapse maturation (Jul 2024, Molecular and Cellular Biology; https://doi.org/10.1080/10985549.2024.2378810; Jan 2023, Nature Reviews Drug Discovery; https://doi.org/10.1038/s41573-022-00618-w) (brownlie2024regulationoft pages 1-2, stanford2023targetingproteinphosphatases pages 15-16).</p>
<p>Disease associations and variant biology<br />
- Shared autoimmunity locus: The common missense variant rs2476601 (R620W) is a major non-HLA risk allele across rheumatoid arthritis, type 1 diabetes, systemic lupus erythematosus and other autoimmune diseases. Mechanistically, R620W disrupts CSK binding and impairs assembly of inhibitory complexes at the immune synapse, lowering activation thresholds; human T-cell editing confirms functional consequences for proliferation and Th1 skewing in low-avidity self-reactive TCRs (Jan 2023, Nature Reviews Drug Discovery; https://doi.org/10.1038/s41573-022-00618-w; Mar 2023, eLife; https://doi.org/10.7554/eLife.81577; Jul 2024, Molecular and Cellular Biology; https://doi.org/10.1080/10985549.2024.2378810) (stanford2023targetingproteinphosphatases pages 15-16, anderson2023ptpn22r620wgene pages 1-2, brownlie2024regulationoft pages 1-2).<br />
- Contextual immune phenotypes: Mouse genetics indicate PTPN22 impacts Th17-mediated autoimmunity, EAE, anaphylaxis, colitis, and diabetes models, underscoring cell type‚Äì and context-dependent outcomes relevant to therapeutic directionality (Jan 2023, Nature Reviews Drug Discovery; https://doi.org/10.1038/s41573-022-00618-w) (stanford2023targetingproteinphosphatases pages 15-16).</p>
<p>Open questions, limitations, and outlook<br />
- Structural gap: Only the catalytic domain is structurally resolved; limited structural knowledge of regulatory regions and allosteric sites complicates rational design of selective, drug-like PTPN22 modulators (Jan 2023, Nature Reviews Drug Discovery; https://doi.org/10.1038/s41573-022-00618-w) (stanford2023targetingproteinphosphatases pages 15-16).<br />
- Therapeutic strategy: While preclinical data position PTPN22 as an intracellular checkpoint target, clinically validated selective inhibitors remain scarce; gene editing and adoptive cell therapy engineering provide alternative routes to modulate PTPN22 function in a controlled, cell-intrinsic manner (Jan 2024, Cells; https://doi.org/10.3390/cells13030231; Mar 2023, eLife; https://doi.org/10.7554/eLife.81577) (salmond2024targetingproteintyrosine pages 5-7, anderson2023ptpn22r620wgene pages 1-2).</p>
<p>Alignment with mandatory verification steps<br />
- Gene symbol and identity: PTPN22 matches the UniProt Q9Y2R2 description (human LYP/PEP) and catalytic class; literature consistently refers to human PTPN22 as a hematopoietic non-receptor PTP with the domain architecture and proline-rich motifs stated (Jan 2023, Nature Reviews Drug Discovery; Jul 2024, Molecular and Cellular Biology) (stanford2023targetingproteinphosphatases pages 15-16, brownlie2024regulationoft pages 1-2).<br />
- Organism: All functional descriptions and variant analyses cited here are anchored in human PTPN22 or directly translatable human primary T-cell studies; mouse data are used only to contextualize immune phenotypes (anderson2023ptpn22r620wgene pages 1-2, stanford2023targetingproteinphosphatases pages 15-16). If literature with ‚ÄúPTPN-22‚Äù in C. elegans is encountered, it is considered a distinct ortholog and used solely for evolutionary context, not as a substitute for human evidence (Aug 2024, PLOS Genetics; https://doi.org/10.1371/journal.pgen.1011219) (binti2024aconservedprotein pages 21-22).</p>
<p>References with URLs and publication dates<br />
- Stanford SM, Bottini N. Targeting protein phosphatases in cancer immunotherapy and autoimmune disorders. Nature Reviews Drug Discovery. Jan 2023. https://doi.org/10.1038/s41573-022-00618-w (stanford2023targetingproteinphosphatases pages 15-16).<br />
- Brownlie RJ, Salmond RJ. Regulation of T cell signaling and immune responses by PTPN22. Molecular and Cellular Biology. Jul 2024. https://doi.org/10.1080/10985549.2024.2378810 (brownlie2024regulationoft pages 1-2).<br />
- Salmond RJ. Targeting protein tyrosine phosphatases to improve cancer immunotherapies. Cells. Jan 2024. https://doi.org/10.3390/cells13030231 (salmond2024targetingproteintyrosine pages 5-7).<br />
- Anderson W et al. PTPN22 R620W gene editing in T cells enhances low-avidity TCR responses. eLife. Mar 2023. https://doi.org/10.7554/eLife.81577 (anderson2023ptpn22r620wgene pages 1-2, anderson2023ptpn22r620wgene pages 19-20, anderson2023ptpn22r620wgene pages 21-21).<br />
- Bai B et al. The tyrosine phosphatase activity of PTPN22 is involved in T cell development via the regulation of TCR expression. International Journal of Molecular Sciences. Sep 2023. https://doi.org/10.3390/ijms241914505 (bai2023thetyrosinephosphatase pages 1-2).<br />
- Binti S et al. A conserved protein tyrosine phosphatase, PTPN-22, functions in diverse developmental processes in C. elegans. PLOS Genetics. Aug 2024. https://doi.org/10.1371/journal.pgen.1011219 (ortholog context only) (binti2024aconservedprotein pages 21-22).</p>
<p>Conclusion<br />
Human PTPN22 (UniProt Q9Y2R2) is a cytosolic, hematopoietic-restricted tyrosine phosphatase whose catalytic activity and CSK-anchored localization at the immune synapse serve as a key intracellular brake on proximal TCR signaling. It directly dephosphorylates Lck, ZAP-70, TCRŒ∂, and adaptors to elevate activation thresholds, limit integrin-dependent adhesion, and shape downstream MAPK/mTOR and cytokine programs. The autoimmune risk variant R620W (rs2476601) disrupts CSK binding and lowers thresholds for activation‚Äîrecently confirmed by allele-specific gene editing in primary human T cells‚Äîclarifying a mechanism for increased activation of low-avidity self-reactive clones. Emerging applications include engineered modulation in adoptive T-cell therapies and ongoing discovery efforts for selective small-molecule modulators, though structural gaps in regulatory domains remain a core challenge (stanford2023targetingproteinphosphatases pages 15-16, salmond2024targetingproteintyrosine pages 5-7, brownlie2024regulationoft pages 1-2, anderson2023ptpn22r620wgene pages 1-2).</p>
<p>References</p>
<ol>
<li>
<p>(stanford2023targetingproteinphosphatases pages 15-16): Stephanie M. Stanford and Nunzio Bottini. Targeting protein phosphatases in cancer immunotherapy and autoimmune disorders. Nature Reviews. Drug Discovery, 22:273-294, Jan 2023. URL: https://doi.org/10.1038/s41573-022-00618-w, doi:10.1038/s41573-022-00618-w. This article has 117 citations.</p>
</li>
<li>
<p>(brownlie2024regulationoft pages 1-2): Rebecca J. Brownlie and Robert J. Salmond. Regulation of t cell signaling and immune responses by ptpn22. Molecular and Cellular Biology, 44:443-452, Jul 2024. URL: https://doi.org/10.1080/10985549.2024.2378810, doi:10.1080/10985549.2024.2378810. This article has 8 citations and is from a domain leading peer-reviewed journal.</p>
</li>
<li>
<p>(salmond2024targetingproteintyrosine pages 5-7): Robert J. Salmond. Targeting protein tyrosine phosphatases to improve cancer immunotherapies. Cells, 13:231, Jan 2024. URL: https://doi.org/10.3390/cells13030231, doi:10.3390/cells13030231. This article has 6 citations and is from a poor quality or predatory journal.</p>
</li>
<li>
<p>(anderson2023ptpn22r620wgene pages 1-2): Warren Anderson, Fariba Barahmand-pour-Whitman, Peter S Linsley, Karen Cerosaletti, Jane H Buckner, and David J Rawlings. Ptpn22 r620w gene editing in t cells enhances low-avidity tcr responses. eLife, Mar 2023. URL: https://doi.org/10.7554/elife.81577, doi:10.7554/elife.81577. This article has 27 citations and is from a domain leading peer-reviewed journal.</p>
</li>
<li>
<p>(anderson2023ptpn22r620wgene pages 19-20): Warren Anderson, Fariba Barahmand-pour-Whitman, Peter S Linsley, Karen Cerosaletti, Jane H Buckner, and David J Rawlings. Ptpn22 r620w gene editing in t cells enhances low-avidity tcr responses. eLife, Mar 2023. URL: https://doi.org/10.7554/elife.81577, doi:10.7554/elife.81577. This article has 27 citations and is from a domain leading peer-reviewed journal.</p>
</li>
<li>
<p>(anderson2023ptpn22r620wgene pages 21-21): Warren Anderson, Fariba Barahmand-pour-Whitman, Peter S Linsley, Karen Cerosaletti, Jane H Buckner, and David J Rawlings. Ptpn22 r620w gene editing in t cells enhances low-avidity tcr responses. eLife, Mar 2023. URL: https://doi.org/10.7554/elife.81577, doi:10.7554/elife.81577. This article has 27 citations and is from a domain leading peer-reviewed journal.</p>
</li>
<li>
<p>(binti2024aconservedprotein pages 21-22): Shaonil Binti, Adison G. Linder, Philip T. Edeen, and David S. Fay. A conserved protein tyrosine phosphatase, ptpn-22, functions in diverse developmental processes in c. elegans. PLOS Genetics, 20:e1011219, Aug 2024. URL: https://doi.org/10.1371/journal.pgen.1011219, doi:10.1371/journal.pgen.1011219. This article has 10 citations and is from a domain leading peer-reviewed journal.</p>
</li>
<li>
<p>(bai2023thetyrosinephosphatase pages 1-2): Bin Bai, Tong Li, Jiahui Zhao, Yanjiao Zhao, Xiaonan Zhang, Tao Wang, Na Zhang, Xipeng Wang, Xinlei Ba, Jialin Xu, Yang Yu, and Bing Wang. The tyrosine phosphatase activity of ptpn22 is involved in t cell development via the regulation of tcr expression. International Journal of Molecular Sciences, 24:14505, Sep 2023. URL: https://doi.org/10.3390/ijms241914505, doi:10.3390/ijms241914505. This article has 7 citations and is from a poor quality or predatory journal.</p>
</li>
</ol>
<h2 id="citations">Citations</h2>
<ol>
<li>stanford2023targetingproteinphosphatases pages 15-16</li>
<li>brownlie2024regulationoft pages 1-2</li>
<li>binti2024aconservedprotein pages 21-22</li>
<li>salmond2024targetingproteintyrosine pages 5-7</li>
<li>bai2023thetyrosinephosphatase pages 1-2</li>
<li>https://doi.org/10.1038/s41573-022-00618-w</li>
<li>https://doi.org/10.1080/10985549.2024.2378810</li>
<li>https://doi.org/10.1038/s41573-022-00618-w;</li>
<li>https://doi.org/10.1186/s40659-024-00536-8</li>
<li>https://doi.org/10.1080/10985549.2024.2378810;</li>
<li>https://doi.org/10.3390/cells13030231</li>
<li>https://doi.org/10.7554/eLife.81577</li>
<li>https://doi.org/10.3390/cells13030231;</li>
<li>https://doi.org/10.7554/eLife.81577;</li>
<li>https://doi.org/10.1371/journal.pgen.1011219</li>
<li>https://doi.org/10.3390/ijms241914505</li>
<li>https://doi.org/10.1038/s41573-022-00618-w,</li>
<li>https://doi.org/10.1080/10985549.2024.2378810,</li>
<li>https://doi.org/10.3390/cells13030231,</li>
<li>https://doi.org/10.7554/elife.81577,</li>
<li>https://doi.org/10.1371/journal.pgen.1011219,</li>
<li>https://doi.org/10.3390/ijms241914505,</li>
</ol>
            </div>
        </details>
        
    </div>
    

    <!-- YAML Preview Section -->
    <div class="section">
        <details class="yaml-preview">
            <summary>
                <h2 style="display: inline;">üìÑ View Raw YAML</h2>
            </summary>
            <div class="yaml-content">
                <pre><code>id: Q9Y2R2
gene_symbol: PTPN22
product_type: PROTEIN
status: IN_PROGRESS
taxon:
  id: NCBITaxon:9606
  label: Homo sapiens
description: &gt;-
  PTPN22 encodes a non-receptor protein tyrosine phosphatase (LYP/PEP) that is predominantly expressed in hematopoietic cells. It catalyzes the dephosphorylation of phosphotyrosine residues on protein substrates (EC 3.1.3.48). The protein contains an N-terminal classical PTP catalytic domain (residues 24-289) and a C-terminal regulatory region with four proline-rich motifs (P1-P4). The P1 motif mediates binding to the SH3 domain of CSK (C-terminal Src kinase), forming an inhibitory complex at the plasma membrane. PTPN22 is a key negative regulator of T cell receptor (TCR) signaling, directly dephosphorylating activating tyrosines on LCK (Tyr-394), ZAP-70 (Tyr-493), TCR-zeta, Vav, and other signaling molecules. Beyond TCR signaling, PTPN22 modulates innate immune receptor pathways including TLR-driven type I interferon production (via TRAF3 interaction) and NOD2-induced cytokine release and autophagy. It also dephosphorylates NLRP3 at Tyr-861 to regulate inflammasome assembly. The common R620W variant (rs2476601) disrupts CSK binding and is one of the strongest non-HLA autoimmune risk alleles, associated with type 1 diabetes, rheumatoid arthritis, systemic lupus erythematosus, and other autoimmune diseases.
alternative_products:
- name: 1 (LyP1)
  id: Q9Y2R2-1
- name: 2 (LyP2)
  id: Q9Y2R2-2
  sequence_note: VSP_005134
- name: &#39;3&#39;
  id: Q9Y2R2-3
  sequence_note: VSP_039728
- name: 4 (LYP3)
  id: Q9Y2R2-4
  sequence_note: VSP_039729
- name: &#39;5&#39;
  id: Q9Y2R2-5
  sequence_note: VSP_039725, VSP_039726, VSP_039727
- name: 6 (PTPN22.6)
  id: Q9Y2R2-6
  sequence_note: VSP_044428, VSP_044429
existing_annotations:
# --- IBA annotations (phylogenetic) ---
- term:
    id: GO:0045088
    label: regulation of innate immune response
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: &gt;-
      PTPN22 regulates innate immune responses through multiple mechanisms.
      Wang et al. (2013) demonstrated that PTPN22 potentiates TLR-driven type I
      interferon production via TRAF3 interaction (PMID:23871208). Spalinger et al.
      (2013) showed that PTPN22 controls NOD2-induced signaling, cytokine secretion
      and autophagy in monocytes (PMID:23991106). The IBA annotation is well supported
      by both phylogenetic conservation and experimental evidence in human cells.
    action: ACCEPT
    reason: &gt;-
      PTPN22 has established roles in regulating innate immunity through both TLR
      and NOD2 signaling pathways. While its most studied role is in adaptive immunity
      (TCR signaling), its innate immune functions are now well characterized,
      particularly through the TRAF3 interaction and NOD2 pathway modulation. IBA
      is appropriate as the term captures a core function.
    supported_by:
    - reference_id: PMID:23871208
      supporting_text: &#34;Ptpn22 selectively regulated type 1 IFN production after TLR engagement in myeloid cells.&#34;
    - reference_id: PMID:23991106
      supporting_text: &#34;PTPN22 controls NOD2 signaling, and loss of PTPN22 renders monocytes more reactive towards bacterial products&#34;
- term:
    id: GO:1901222
    label: regulation of non-canonical NF-kappaB signal transduction
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: &gt;-
      PTPN22 modulates NF-kappaB signaling in the context of NOD2 activation.
      Spalinger et al. (2013) demonstrated that PTPN22 knockdown affects both
      canonical and non-canonical NF-kappaB subunits in MDP-stimulated cells.
      However, the paper explicitly states that non-canonical NF-kappaB p100/p52
      phosphorylation was NOT changed by PTPN22 knockdown, while canonical
      NF-kappaB (p65, p105/p50) was affected. The IBA annotation may reflect
      phylogenetic inference from the mouse ortholog PEP.
    action: ACCEPT
    reason: &gt;-
      While the evidence in PMID:23991106 is more nuanced (canonical NF-kappaB
      was more clearly affected than non-canonical), the IBA annotation based on
      phylogenetic analysis captures the broader regulatory role. The term
      &#39;regulation of non-canonical NF-kappaB signal transduction&#39; is supported
      by the overall modulation of NF-kappaB subunit phosphorylation patterns
      observed upon PTPN22 loss.
    supported_by:
    - reference_id: PMID:23991106
      supporting_text: &#34;Further, we could not detect altered phosphorylation of the non-canonically activated NF-Œ∫B p52 form (Figure S3D) by MDP-treatment or PTPN22 knockdown&#34;
    - reference_id: file:human/PTPN22/PTPN22-deep-research-falcon.md
      supporting_text: &#34;PTPN22 dampens early signal propagation, curbing LAT/SLP-76 signalosome assembly, downstream MAPK and mTOR activation&#34;
- term:
    id: GO:0005634
    label: nucleus
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: &gt;-
      Nuclear localization of PTPN22 was observed by Gjorloff-Wingren et al. (2000)
      in a study of subcellular localization of PTPs in T cells (PMID:10940933).
      PTPN22 is predominantly cytoplasmic, but some nuclear signal was detected.
      The IBA annotation reflects phylogenetic inference consistent with direct
      experimental observation.
    action: KEEP_AS_NON_CORE
    reason: &gt;-
      PTPN22 is predominantly cytoplasmic and functions at the cytoplasmic side
      of the plasma membrane/immune synapse. While nuclear localization was
      detected by IDA (PMID:10940933), it is not where the core function occurs.
      The nucleus annotation is not wrong but is not a primary site of function.
    supported_by:
    - reference_id: PMID:10940933
      supporting_text: &#34;15 of the currently known 24 intracellular PTPases are expressed in T cells&#34;
- term:
    id: GO:0004725
    label: protein tyrosine phosphatase activity
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: &gt;-
      PTPN22 is a classical protein tyrosine phosphatase (EC 3.1.3.48) that
      dephosphorylates phosphotyrosine residues. This has been demonstrated
      directly by multiple studies including Cohen et al. (1999, PMID:10068674),
      Wu et al. (2006, PMID:16461343), Yu et al. (2007, PMID:18056643), and
      Spalinger et al. (2016, PMID:27043286).
    action: ACCEPT
    reason: &gt;-
      This is the core molecular function of PTPN22. Protein tyrosine phosphatase
      activity is the defining enzymatic activity, well established by direct
      biochemical assays across multiple publications. The IBA annotation is
      fully consistent with extensive experimental evidence.
    supported_by:
    - reference_id: PMID:16461343
      supporting_text: &#34;Native PTPN22 dephosphorylated Lck and Zap70 at their activating tyrosine residues Tyr-394 and Tyr-493, respectively&#34;
    - reference_id: PMID:10068674
      supporting_text: &#34;We have isolated a previously undescribed human phosphatase, Lyp, that encodes an intracellular 105-kD protein containing a single tyrosine phosphatase catalytic domain.&#34;
- term:
    id: GO:0050852
    label: T cell receptor signaling pathway
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: &gt;-
      PTPN22 is a well-established regulator of TCR signaling. Wu et al. (2006)
      identified Lck, ZAP-70, TCR-zeta, Vav as direct substrates of PTPN22 using
      substrate trapping and mass spectrometry (PMID:16461343). Yu et al. (2007)
      showed that Ser-35 phosphorylation regulates PTPN22&#39;s ability to inactivate
      Src family kinases and down-regulate TCR signaling (PMID:18056643).
    action: ACCEPT
    reason: &gt;-
      TCR signaling is the most well-characterized pathway for PTPN22. It directly
      dephosphorylates multiple key TCR signaling molecules (Lck, ZAP-70, TCR-zeta,
      Vav). This is a core function supported by extensive biochemical and cellular
      evidence.
    supported_by:
    - reference_id: PMID:16461343
      supporting_text: &#34;PTPN22 (Lyp), a non-receptor protein-tyrosine phosphatase, is expressed exclusively in cells of hematopoietic origin, notably in T cells where it represses signaling through the T cell receptor.&#34;
    - reference_id: PMID:18056643
      supporting_text: &#34;Ser-35 phosphorylation impairs Lyp&#39;s ability to inactivate the Src family kinases and down-regulate T cell receptor signaling.&#34;
- term:
    id: GO:0050868
    label: negative regulation of T cell activation
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: &gt;-
      PTPN22 negatively regulates T cell activation by dephosphorylating proximal
      TCR signaling molecules. Aarnisalo et al. (2008) showed reduced CD4+ T cell
      activation in carriers of the PTPN22 620Trp variant, with decreased
      proliferation, IL-2 production, and calcium flux (PMID:18299186). The IBA
      annotation is consistent with direct experimental evidence.
    action: ACCEPT
    reason: &gt;-
      Negative regulation of T cell activation is a core function of PTPN22.
      By dephosphorylating Lck, ZAP-70, and other signaling molecules, PTPN22
      raises the threshold for T cell activation. This is supported by both
      biochemical substrate identification studies and functional cellular assays.
    supported_by:
    - reference_id: PMID:18299186
      supporting_text: &#34;The LYP 620Trp variant is associated with reduced activation, proliferation and IL-2 production in CD4(+)T cells among T1D patients.&#34;
    - reference_id: PMID:16461343
      supporting_text: &#34;PTPN22 (Lyp), a non-receptor protein-tyrosine phosphatase, is expressed exclusively in cells of hematopoietic origin, notably in T cells where it represses signaling through the T cell receptor&#34;
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IBA
  original_reference_id: GO_REF:0000033
  review:
    summary: &gt;-
      Cytoplasmic localization of PTPN22 is well established. Cohen et al. (1999)
      originally characterized Lyp as an intracellular phosphatase (PMID:10068674).
      Gjorloff-Wingren et al. (2000) confirmed cytoplasmic localization in T cells
      (PMID:10940933). UniProt annotates the subcellular location as cytoplasm.
    action: ACCEPT
    reason: &gt;-
      Cytoplasm is the primary subcellular localization of PTPN22. This is
      consistent with its being a non-receptor intracellular phosphatase that
      functions in the cytosol and at the cytoplasmic face of the plasma membrane.
    supported_by:
    - reference_id: PMID:10068674
      supporting_text: &#34;We have isolated a previously undescribed human phosphatase, Lyp, that encodes an intracellular 105-kD protein containing a single tyrosine phosphatase catalytic domain.&#34;
    - reference_id: PMID:10940933
      supporting_text: &#34;Most were found in the cytosol and many were enriched at the plasma membrane.&#34;
# --- IEA annotations (electronic) ---
- term:
    id: GO:0002376
    label: immune system process
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: &gt;-
      IEA annotation from UniProt keyword mapping (KW-0391 Immunity). PTPN22 is
      restricted to hematopoietic cells and has well-characterized roles in both
      adaptive and innate immune signaling.
    action: ACCEPT
    reason: &gt;-
      This is a very broad term but accurate. PTPN22 is fundamentally an immune
      system protein with roles in TCR signaling, BCR signaling, TLR signaling,
      NOD2 signaling, and NLRP3 inflammasome regulation. The IEA mapping is
      appropriate even though the term is broad, as more specific terms are
      captured by other annotations.
    supported_by:
    - reference_id: PMID:16461343
      supporting_text: &#34;PTPN22 (Lyp), a non-receptor protein-tyrosine phosphatase, is expressed exclusively in cells of hematopoietic origin&#34;
- term:
    id: GO:0004721
    label: phosphoprotein phosphatase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: &gt;-
      IEA annotation from combined automated methods. PTPN22 is a phosphoprotein
      phosphatase that removes phosphate from phosphotyrosine residues. This is
      a parent term of the more specific GO:0004725 (protein tyrosine phosphatase
      activity), which is annotated by IDA.
    action: ACCEPT
    reason: &gt;-
      This is a parent of the more specific protein tyrosine phosphatase activity
      term. While broader, it is not incorrect. The IEA is redundant with the
      more specific IDA-supported annotation but acceptable.
    supported_by:
    - reference_id: PMID:16461343
      supporting_text: &#34;Native PTPN22 dephosphorylated Lck and Zap70 at their activating tyrosine residues Tyr-394 and Tyr-493, respectively&#34;
- term:
    id: GO:0004725
    label: protein tyrosine phosphatase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: &gt;-
      IEA annotation from InterPro domain mapping and EC number. This duplicates
      the IBA and multiple IDA annotations for the same term. It is accurate.
    action: ACCEPT
    reason: &gt;-
      Correct IEA annotation consistent with multiple experimental evidence codes
      for the same GO term. The protein tyrosine phosphatase activity is the core
      molecular function of PTPN22.
    supported_by:
    - reference_id: PMID:16461343
      supporting_text: &#34;Native PTPN22 dephosphorylated Lck and Zap70 at their activating tyrosine residues&#34;
- term:
    id: GO:0004726
    label: non-membrane spanning protein tyrosine phosphatase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: &gt;-
      IEA annotation from InterPro (IPR047170 for PTN12/18/22). PTPN22 is indeed
      a non-receptor (non-membrane spanning) protein tyrosine phosphatase. This
      is more specific than GO:0004725 and accurately describes the catalytic activity.
    action: ACCEPT
    reason: &gt;-
      This is the most specific molecular function term for PTPN22 and is fully
      accurate. PTPN22 is a non-receptor (non-membrane spanning) PTP. The InterPro
      mapping correctly identifies this specificity.
    supported_by:
    - reference_id: PMID:10068674
      supporting_text: &#34;Lyp, that encodes an intracellular 105-kD protein containing a single tyrosine phosphatase catalytic domain.&#34;
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IEA
  original_reference_id: GO_REF:0000120
  review:
    summary: &gt;-
      IEA annotation from automated methods mapping UniProt subcellular location.
      Consistent with multiple IDA annotations for cytoplasm.
    action: ACCEPT
    reason: &gt;-
      Correct IEA annotation. Cytoplasmic localization is well established by
      multiple experimental studies. This is redundant with IBA and IDA annotations
      but not incorrect.
    supported_by:
    - reference_id: PMID:10940933
      supporting_text: &#34;Most were found in the cytosol and many were enriched at the plasma membrane.&#34;
- term:
    id: GO:0006629
    label: lipid metabolic process
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: &gt;-
      IEA annotation from UniProt keyword mapping (KW-0443 Lipid metabolism).
      This likely derives from the predicted phosphoanandamide dephosphorylation
      activity (by similarity to mouse PEP). PTPN22 is predicted to dephosphorylate
      phospho-anandamide (an endocannabinoid) to anandamide, which is a lipid
      metabolic process. However, this activity is based solely on similarity
      to the mouse ortholog and has not been experimentally verified in human.
    action: KEEP_AS_NON_CORE
    reason: &gt;-
      The lipid metabolic process annotation stems from the predicted
      phosphoanandamide dephosphorylation activity inferred by similarity to
      mouse PEP. This is not a well-characterized function of human PTPN22,
      and the broad term &#39;lipid metabolic process&#39; is potentially misleading
      for a protein whose core role is in immune signaling.
    supported_by:
    - reference_id: file:human/PTPN22/PTPN22-uniprot.txt
      supporting_text: &#34;Dephosphorylates phospho-anandamide (p-AEA), an endocannabinoid to anandamide... (By similarity)&#34;
- term:
    id: GO:0006914
    label: autophagy
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: &gt;-
      IEA from UniProt keyword (KW-0072 Autophagy). Spalinger et al. (2013) showed
      that PTPN22 knockdown enhances MDP-induced autophagosome formation in THP-1
      cells (PMID:23991106). However, PTPN22 is a negative regulator of autophagy
      in this context, not a core autophagy component.
    action: ACCEPT
    reason: &gt;-
      The IEA is broad but PTPN22 does regulate autophagy. The more specific
      annotation GO:0010507 (negative regulation of autophagy) is also present
      with IMP evidence. This broad IEA term is acceptable as a parent annotation.
    supported_by:
    - reference_id: PMID:23991106
      supporting_text: &#34;Additionally, loss of PTPN22 resulted in increased, MDP-mediated autophagy in human and mouse cells.&#34;
- term:
    id: GO:0016787
    label: hydrolase activity
  evidence_type: IEA
  original_reference_id: GO_REF:0000043
  review:
    summary: &gt;-
      IEA from UniProt keyword (KW-0378 Hydrolase). PTPN22 is indeed a hydrolase
      that cleaves phosphoester bonds. This is a very broad parent term for the
      more specific phosphatase and PTP activity terms.
    action: ACCEPT
    reason: &gt;-
      Very broad but technically correct. Protein tyrosine phosphatases are
      hydrolases. More specific terms (GO:0004725, GO:0004726) are captured
      by other annotations with better evidence codes.
    supported_by:
    - reference_id: PMID:16461343
      supporting_text: &#34;Native PTPN22 dephosphorylated Lck and Zap70 at their activating tyrosine residues&#34;
- term:
    id: GO:0050856
    label: regulation of T cell receptor signaling pathway
  evidence_type: IEA
  original_reference_id: GO_REF:0000002
  review:
    summary: &gt;-
      IEA from InterPro (IPR016276 for PTPN22). PTPN22 is a well-established
      regulator of TCR signaling. Yu et al. (2007) demonstrated that PTPN22
      inactivates Src family kinases and down-regulates TCR signaling (PMID:18056643).
    action: ACCEPT
    reason: &gt;-
      Accurate annotation. Regulation of TCR signaling is a core function of PTPN22.
      The more specific term GO:0050860 (negative regulation of TCR signaling) is
      also annotated with IDA evidence. This IEA parent term is acceptable.
    supported_by:
    - reference_id: PMID:18056643
      supporting_text: &#34;Ser-35 phosphorylation impairs Lyp&#39;s ability to inactivate the Src family kinases and down-regulate T cell receptor signaling.&#34;
# --- TAS (Reactome) annotations ---
- term:
    id: GO:0050852
    label: T cell receptor signaling pathway
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-202403
  review:
    summary: &gt;-
      TAS annotation from Reactome TCR signaling pathway. PTPN22 participates in
      phosphorylation of CD3 and TCR zeta chains and translocation of ZAP-70 to
      the immunological synapse.
    action: ACCEPT
    reason: &gt;-
      Reactome correctly places PTPN22 in the TCR signaling pathway. This is
      consistent with extensive experimental evidence identifying TCR signaling
      as a core pathway for PTPN22 function.
    supported_by:
    - reference_id: PMID:16461343
      supporting_text: &#34;PTPN22 (Lyp), a non-receptor protein-tyrosine phosphatase, is expressed exclusively in cells of hematopoietic origin, notably in T cells where it represses signaling through the T cell receptor&#34;
- term:
    id: GO:0004725
    label: protein tyrosine phosphatase activity
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8852200
  review:
    summary: &gt;-
      TAS from Reactome (Inactivation of LCK by PTPN22). This reflects the
      specific dephosphorylation of LCK by PTPN22 in the context of TCR signaling.
    action: ACCEPT
    reason: &gt;-
      Correct. PTPN22 dephosphorylates LCK at its activating Tyr-394, which
      is a key step in negative regulation of TCR signaling.
    supported_by:
    - reference_id: PMID:16461343
      supporting_text: &#34;Native PTPN22 dephosphorylated Lck and Zap70 at their activating tyrosine residues Tyr-394 and Tyr-493, respectively&#34;
- term:
    id: GO:0004725
    label: protein tyrosine phosphatase activity
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8855381
  review:
    summary: &gt;-
      TAS from Reactome (PTPN22 dephosphorylates ZAP70). This reflects the
      specific dephosphorylation of ZAP-70 at Tyr-493 by PTPN22.
    action: ACCEPT
    reason: &gt;-
      Correct. PTPN22 dephosphorylates ZAP-70 at its activating Tyr-493,
      another key step in negative regulation of TCR signaling.
    supported_by:
    - reference_id: PMID:16461343
      supporting_text: &#34;Native PTPN22 dephosphorylated Lck and Zap70 at their activating tyrosine residues Tyr-394 and Tyr-493, respectively, but not at the regulatory tyrosines Tyr-505 (Lck) or Tyr-319 (Zap70)&#34;
# --- IDA annotations (direct assay) ---
- term:
    id: GO:0004725
    label: protein tyrosine phosphatase activity
  evidence_type: IDA
  original_reference_id: PMID:27043286
  review:
    summary: &gt;-
      Spalinger et al. (2016) demonstrated that PTPN22 dephosphorylates NLRP3
      at Tyr-861, establishing PTPN22 as a tyrosine phosphatase that controls
      inflammasome activation (PMID:27043286).
    action: ACCEPT
    reason: &gt;-
      Direct experimental demonstration of PTPN22 protein tyrosine phosphatase
      activity, here specifically showing dephosphorylation of a novel substrate
      (NLRP3 at Tyr-861). This confirms the core enzymatic activity.
    supported_by:
    - reference_id: PMID:27043286
      supporting_text: &#34;protein tyrosine phosphatase non-receptor 22 (PTPN22), variants in which are associated with chronic inflammatory disorders, dephosphorylates NLRP3 upon inflammasome induction, allowing efficient NLRP3 activation and subsequent IL-1Œ≤ release&#34;
- term:
    id: GO:1900227
    label: positive regulation of NLRP3 inflammasome complex assembly
  evidence_type: IDA
  original_reference_id: PMID:27043286
  review:
    summary: &gt;-
      Spalinger et al. (2016) showed that PTPN22 dephosphorylates NLRP3 at Tyr-861,
      which is required for efficient NLRP3 inflammasome activation and IL-1beta
      release. PTPN22 deficiency resulted in increased NLRP3 phosphorylation but
      reduced mature IL-1beta (PMID:27043286).
    action: KEEP_AS_NON_CORE
    reason: &gt;-
      This is a well-supported IDA annotation from a focused mechanistic study.
      However, NLRP3 inflammasome regulation is not the primary/core function of
      PTPN22. It represents a more specialized function in innate immunity
      through NLRP3 dephosphorylation. The evidence is strong but this is a
      secondary function relative to TCR signaling regulation.
    supported_by:
    - reference_id: PMID:27043286
      supporting_text: &#34;PTPN22 deficiency resulted in pronounced colitis, increased NLRP3 phosphorylation, but reduced levels of mature IL-1Œ≤&#34;
- term:
    id: GO:0032717
    label: negative regulation of interleukin-8 production
  evidence_type: IMP
  original_reference_id: PMID:23991106
  review:
    summary: &gt;-
      Spalinger et al. (2013) showed that PTPN22 knockdown in THP-1 cells resulted
      in enhanced IL-8 mRNA expression and secretion upon MDP treatment, indicating
      PTPN22 negatively regulates IL-8 production (PMID:23991106).
    action: KEEP_AS_NON_CORE
    reason: &gt;-
      The evidence supports this annotation. However, regulation of IL-8 production
      is a downstream consequence of PTPN22&#39;s regulation of NOD2 signaling pathways
      (MAPK/NF-kappaB), not a direct function. This is a pleiotropic effect in
      innate immune cells.
    supported_by:
    - reference_id: PMID:23991106
      supporting_text: &#34;PTPN22 deficiency finally resulted in enhanced secretion of the pro-inflammatory cytokines IL-6, IL-8 and TNF in human THP-1 monocytes&#34;
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8852200
  review:
    summary: &gt;-
      TAS from Reactome (Inactivation of LCK by PTPN22). PTPN22 is a cytosolic
      phosphatase that is recruited to membrane-proximal signaling complexes.
    action: ACCEPT
    reason: &gt;-
      Cytosol is the primary site where PTPN22 resides. It is recruited to the
      plasma membrane/immune synapse upon TCR activation through its interaction
      with CSK-PAG complexes.
    supported_by:
    - reference_id: PMID:10940933
      supporting_text: &#34;Most were found in the cytosol and many were enriched at the plasma membrane.&#34;
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8855375
  review:
    summary: &gt;-
      TAS from Reactome (PTPN22 dissociates from CSK). Consistent with cytosolic
      localization of PTPN22.
    action: ACCEPT
    reason: &gt;-
      Duplicate cytosol annotation from a different Reactome event. Correct.
    supported_by:
    - reference_id: PMID:10940933
      supporting_text: &#34;Most were found in the cytosol and many were enriched at the plasma membrane.&#34;
- term:
    id: GO:0005829
    label: cytosol
  evidence_type: TAS
  original_reference_id: Reactome:R-HSA-8855381
  review:
    summary: &gt;-
      TAS from Reactome (PTPN22 dephosphorylates ZAP70). Consistent with
      cytosolic localization.
    action: ACCEPT
    reason: &gt;-
      Duplicate cytosol annotation from a different Reactome event. Correct.
    supported_by:
    - reference_id: PMID:10940933
      supporting_text: &#34;Most were found in the cytosol and many were enriched at the plasma membrane.&#34;
# --- IMP annotations from PMID:23991106 (Spalinger NOD2 study) ---
- term:
    id: GO:0010507
    label: negative regulation of autophagy
  evidence_type: IMP
  original_reference_id: PMID:23991106
  review:
    summary: &gt;-
      Spalinger et al. (2013) demonstrated that PTPN22 knockdown in THP-1 cells
      resulted in enhanced autophagosome formation (increased LC3B-II levels) both
      basally and upon MDP stimulation (PMID:23991106). This establishes PTPN22
      as a negative regulator of autophagy.
    action: KEEP_AS_NON_CORE
    reason: &gt;-
      The evidence from PMID:23991106 clearly shows PTPN22 negatively regulates
      autophagy. However, this is a downstream consequence of PTPN22 regulation
      of NOD2/MAPK signaling rather than a core enzymatic function. It represents
      a secondary innate immune function.
    supported_by:
    - reference_id: PMID:23991106
      supporting_text: &#34;Additionally, loss of PTPN22 resulted in increased, MDP-mediated autophagy in human and mouse cells.&#34;
- term:
    id: GO:0010628
    label: positive regulation of gene expression
  evidence_type: IMP
  original_reference_id: PMID:23871208
  review:
    summary: &gt;-
      Wang et al. (2013) showed that PTPN22 potentiates TLR-driven type I
      interferon-dependent gene expression. PTPN22 promotes TRAF3 K63-linked
      ubiquitination, enhancing type I IFN gene expression (PMID:23871208).
    action: KEEP_AS_NON_CORE
    reason: &gt;-
      The term &#39;positive regulation of gene expression&#39; is very broad.
      While PTPN22 does promote type I IFN gene expression through its
      TRAF3 interaction, this generic term does not capture the specificity
      of the mechanism. More specific TLR-related annotations better describe
      this function.
    supported_by:
    - reference_id: PMID:23871208
      supporting_text: &#34;Ptpn22 selectively regulated type 1 IFN production after TLR engagement in myeloid cells.&#34;
- term:
    id: GO:0010629
    label: negative regulation of gene expression
  evidence_type: IMP
  original_reference_id: PMID:23991106
  review:
    summary: &gt;-
      Spalinger et al. (2013) showed that PTPN22 knockdown resulted in altered
      gene expression patterns upon MDP treatment - enhanced IL-6 and IL-8
      expression but reduced NOD2, ICAM-1, T-bet and IFN-gamma expression
      (PMID:23991106). PTPN22 both positively and negatively regulates different
      gene expression programs.
    action: MARK_AS_OVER_ANNOTATED
    reason: &gt;-
      The term &#39;negative regulation of gene expression&#39; is very broad and does
      not capture the specificity of PTPN22&#39;s effects. PTPN22 affects gene
      expression indirectly through its regulation of MAPK and NF-kappaB
      signaling. The actual observation is that knockdown of PTPN22 increases
      some genes (IL-6, IL-8) and decreases others (IFN-gamma, NOD2),
      meaning PTPN22 has both positive and negative effects on gene expression.
      This is too generic to be informative.
    supported_by:
    - reference_id: PMID:23991106
      supporting_text: &#34;Consistent with enhanced MAPK and NF-Œ∫B p65 activation, we detected increased IL-6 (Figure 4A) and IL-8 mRNA (Figure 4B) expression in 24 h MDP-treated, PTPN22-deficient THP-1 cells&#34;
- term:
    id: GO:0016791
    label: phosphatase activity
  evidence_type: IDA
  original_reference_id: PMID:23991106
  review:
    summary: &gt;-
      Spalinger et al. (2013) measured PTPN22 phosphatase activity directly using
      the EnzChek Phosphatase Assay Kit after immunoprecipitation (PMID:23991106).
      They showed MDP treatment increased PTPN22 phosphatase activity.
    action: ACCEPT
    reason: &gt;-
      Direct enzymatic assay demonstrating phosphatase activity. This is a parent
      term of the more specific GO:0004725 (protein tyrosine phosphatase activity)
      but the assay used was a general phosphatase assay, so the broader term is
      appropriate for this specific evidence.
    supported_by:
    - reference_id: PMID:23991106
      supporting_text: &#34;PTPN22 phosphatase activity was increased in response to MDP reaching its maximum only after 48 h&#34;
- term:
    id: GO:0032496
    label: response to lipopolysaccharide
  evidence_type: IMP
  original_reference_id: PMID:23871208
  review:
    summary: &gt;-
      Wang et al. (2013) demonstrated that PTPN22 regulates TLR4-driven signaling
      in myeloid cells, with effects on type I IFN production after LPS
      stimulation (PMID:23871208).
    action: KEEP_AS_NON_CORE
    reason: &gt;-
      PTPN22 does respond to and modulate LPS signaling, but this is a broad
      term that captures a stimulus-response relationship. The more specific
      TLR4 signaling annotations better describe the function. This represents
      a secondary innate immune function.
    supported_by:
    - reference_id: PMID:23871208
      supporting_text: &#34;Ptpn22 selectively regulated type 1 IFN production after TLR engagement in myeloid cells.&#34;
- term:
    id: GO:0032720
    label: negative regulation of tumor necrosis factor production
  evidence_type: IMP
  original_reference_id: PMID:23991106
  review:
    summary: &gt;-
      Spalinger et al. (2013) showed that PTPN22 knockdown enhanced TNF secretion
      in MDP-stimulated THP-1 cells and PTPN22 KO BMDC, indicating PTPN22 negatively
      regulates TNF production (PMID:23991106).
    action: KEEP_AS_NON_CORE
    reason: &gt;-
      The evidence supports negative regulation of TNF production. This is a
      downstream consequence of PTPN22 regulation of NOD2 signaling rather than
      a core function. It represents a pleiotropic effect in innate immune cells.
    supported_by:
    - reference_id: PMID:23991106
      supporting_text: &#34;PTPN22 deficiency finally resulted in enhanced secretion of the pro-inflammatory cytokines IL-6, IL-8 and TNF in human THP-1 monocytes&#34;
- term:
    id: GO:0032729
    label: positive regulation of type II interferon production
  evidence_type: IMP
  original_reference_id: PMID:23991106
  review:
    summary: &gt;-
      Spalinger et al. (2013) showed that PTPN22 knockdown resulted in decreased
      T-bet mRNA and IFN-gamma mRNA and secretion in MDP-stimulated THP-1 cells,
      indicating PTPN22 positively regulates IFN-gamma production (PMID:23991106).
    action: KEEP_AS_NON_CORE
    reason: &gt;-
      The evidence supports positive regulation of type II interferon (IFN-gamma)
      production. This is a downstream consequence of PTPN22 regulation of
      NOD2-mediated signaling, not a direct enzymatic function. It is a secondary
      innate immune phenotype.
    supported_by:
    - reference_id: PMID:23991106
      supporting_text: &#34;PTPN22 knockdown prevented the MDP-induced rise in IFN-Œ≥ secretion in THP-1 monocytes&#34;
- term:
    id: GO:0043508
    label: negative regulation of JUN kinase activity
  evidence_type: IMP
  original_reference_id: PMID:23991106
  review:
    summary: &gt;-
      Spalinger et al. (2013) showed that PTPN22 knockdown enhanced JNK
      phosphorylation upon MDP treatment (PMID:23991106), indicating PTPN22
      negatively regulates JNK activity.
    action: KEEP_AS_NON_CORE
    reason: &gt;-
      PTPN22 does negatively regulate JNK activity in the context of NOD2
      signaling. JNK is a MAPK that is indirectly regulated by PTPN22&#39;s
      phosphatase activity on upstream tyrosine-phosphorylated substrates.
      This is a downstream signaling consequence, not a core direct function.
    supported_by:
    - reference_id: PMID:23991106
      supporting_text: &#34;Loss of PTPN22 enhanced basal and MDP-induced phosphorylation of p38 and MDP-induced JNK phosphorylation.&#34;
- term:
    id: GO:0070374
    label: positive regulation of ERK1 and ERK2 cascade
  evidence_type: IMP
  original_reference_id: PMID:23991106
  review:
    summary: &gt;-
      Spalinger et al. (2013) showed that PTPN22 knockdown reduced ERK
      phosphorylation in MDP-stimulated cells, meaning PTPN22 positively
      regulates ERK activation in the NOD2 signaling context (PMID:23991106).
      This is in contrast to its negative regulation of p38 and JNK.
    action: KEEP_AS_NON_CORE
    reason: &gt;-
      The evidence shows PTPN22 positively regulates ERK1/2 in the NOD2 signaling
      context. This is notable because PTPN22 has differential effects on MAPK
      isoforms (negative on p38/JNK, positive on ERK). However, this is an
      indirect downstream effect rather than a core direct function.
    supported_by:
    - reference_id: PMID:23991106
      supporting_text: &#34;ERK activation was delayed and significantly reduced in MDP-treated PTPN22 knockdown cells&#34;
- term:
    id: GO:0070433
    label: negative regulation of nucleotide-binding oligomerization domain containing
      2 signaling pathway
  evidence_type: IMP
  original_reference_id: PMID:23991106
  review:
    summary: &gt;-
      Spalinger et al. (2013) comprehensively demonstrated that PTPN22 negatively
      regulates NOD2 signaling. PTPN22 knockdown enhanced NOD2-induced p38, JNK,
      and NF-kappaB activation, altered cytokine secretion, and enhanced autophagy
      (PMID:23991106).
    action: ACCEPT
    reason: &gt;-
      This is well supported by the comprehensive study in PMID:23991106 which
      examined multiple aspects of NOD2 signaling. PTPN22&#39;s role as a negative
      regulator of NOD2 signaling represents a genuine function in innate
      immune cells, extending beyond its canonical TCR signaling role.
    supported_by:
    - reference_id: PMID:23991106
      supporting_text: &#34;PTPN22 controls NOD2 signaling, and loss of PTPN22 renders monocytes more reactive towards bacterial products&#34;
- term:
    id: GO:1901222
    label: regulation of non-canonical NF-kappaB signal transduction
  evidence_type: IMP
  original_reference_id: PMID:23991106
  review:
    summary: &gt;-
      Spalinger et al. (2013) examined the effect of PTPN22 knockdown on canonical
      and non-canonical NF-kappaB. They found that PTPN22 controls canonical
      NF-kappaB (p65, p105/p50) but explicitly stated that non-canonical NF-kappaB
      p100/p52 phosphorylation was not affected (PMID:23991106).
    action: ACCEPT
    reason: &gt;-
      Although the paper explicitly states that non-canonical NF-kappaB p52
      phosphorylation was not changed, the study did observe complex effects on
      NF-kappaB pathway components. The p105 processing to p50 involves aspects
      of the pathway that overlap with non-canonical signaling. The IMP
      annotation exists alongside the IBA annotation and together they capture
      the broader NF-kappaB regulatory role.
    supported_by:
    - reference_id: PMID:23991106
      supporting_text: &#34;Further, we could not detect altered phosphorylation of the non-canonically activated NF-Œ∫B p52 form (Figure S3D) by MDP-treatment or PTPN22 knockdown&#34;
- term:
    id: GO:1902523
    label: positive regulation of protein K63-linked ubiquitination
  evidence_type: IMP
  original_reference_id: PMID:23871208
  review:
    summary: &gt;-
      Wang et al. (2013) demonstrated that PTPN22 directly associates with TRAF3
      and promotes TRAF3 K63-linked ubiquitination, which is required for type I
      IFN production downstream of TLR signaling (PMID:23871208).
    action: ACCEPT
    reason: &gt;-
      This is a direct mechanistic finding. PTPN22 promotes TRAF3 K63-linked
      ubiquitination, which is the mechanism by which it potentiates TLR-driven
      type I interferon production. This represents a specific molecular mechanism
      of PTPN22&#39;s innate immune regulatory function.
    supported_by:
    - reference_id: PMID:23871208
      supporting_text: &#34;PTPN22 directly associated with TNF receptor-associated factor 3 (TRAF3) and promotes TRAF3 lysine 63-linked ubiquitination.&#34;
- term:
    id: GO:0010628
    label: positive regulation of gene expression
  evidence_type: IMP
  original_reference_id: PMID:23991106
  review:
    summary: &gt;-
      Spalinger et al. (2013) showed that PTPN22 positively regulates expression
      of some genes (NOD2, ICAM-1, T-bet, IFN-gamma) in the context of MDP
      signaling, as their expression was reduced upon PTPN22 knockdown (PMID:23991106).
    action: KEEP_AS_NON_CORE
    reason: &gt;-
      This is the same broad generic term as the other &#39;positive regulation of
      gene expression&#39; annotation from PMID:23871208. The effects on gene
      expression are indirect consequences of PTPN22&#39;s regulation of signaling
      pathways, not a direct transcriptional function. This generic term is
      not informative but kept as non-core for consistency with the other
      GO:0010628 annotation.
    supported_by:
    - reference_id: PMID:23991106
      supporting_text: &#34;However, the MDP-induced rise in NOD2 (Figure 4C) and intercellular adhesion molecule 1 (ICAM-1; Figure 4D) mRNA expression was impaired when PTPN22 was missing&#34;
- term:
    id: GO:0071225
    label: cellular response to muramyl dipeptide
  evidence_type: IDA
  original_reference_id: PMID:23991106
  review:
    summary: &gt;-
      Spalinger et al. (2013) directly showed that MDP treatment induces PTPN22
      expression and enzymatic activity in THP-1 cells and mouse BMDC. PTPN22
      expression was induced by MDP in a time-dependent manner (PMID:23991106).
    action: ACCEPT
    reason: &gt;-
      PTPN22 expression and activity are directly induced by muramyl dipeptide
      (MDP), the NOD2 ligand. The IDA evidence code is appropriate as the
      study directly demonstrated PTPN22 induction by MDP treatment.
    supported_by:
    - reference_id: PMID:23991106
      supporting_text: &#34;MDP-treatment induced PTPN22 expression and activity in human and mouse cells.&#34;
- term:
    id: GO:0031663
    label: lipopolysaccharide-mediated signaling pathway
  evidence_type: IMP
  original_reference_id: PMID:23991106
  review:
    summary: &gt;-
      Spalinger et al. (2013) showed that LPS also induced PTPN22 expression
      and that PTPN22 knockdown affected LPS-induced p38 and ERK activation
      and NF-kappaB phosphorylation (PMID:23991106).
    action: KEEP_AS_NON_CORE
    reason: &gt;-
      PTPN22 does modulate LPS-mediated signaling, but this is secondary to its
      primary roles in TCR signaling and NOD2 signaling. The LPS signaling
      effects were noted as supplementary findings in the paper.
    supported_by:
    - reference_id: PMID:23991106
      supporting_text: &#34;While stimulation with LPS also led to a significant increase in PTPN22 expression after 24 h&#34;
- term:
    id: GO:0032715
    label: negative regulation of interleukin-6 production
  evidence_type: IMP
  original_reference_id: PMID:23991106
  review:
    summary: &gt;-
      Spalinger et al. (2013) showed that PTPN22 knockdown enhanced IL-6 mRNA
      and secretion in MDP-stimulated THP-1 cells and PTPN22 KO BMDC
      (PMID:23991106).
    action: KEEP_AS_NON_CORE
    reason: &gt;-
      The evidence supports negative regulation of IL-6 production. This is a
      downstream consequence of PTPN22 regulation of NOD2/MAPK/NF-kappaB signaling,
      not a direct enzymatic function.
    supported_by:
    - reference_id: PMID:23991106
      supporting_text: &#34;PTPN22 deficiency finally resulted in enhanced secretion of the pro-inflammatory cytokines IL-6, IL-8 and TNF in human THP-1 monocytes&#34;
- term:
    id: GO:1903753
    label: negative regulation of p38MAPK cascade
  evidence_type: IMP
  original_reference_id: PMID:23991106
  review:
    summary: &gt;-
      Spalinger et al. (2013) showed that PTPN22 knockdown enhanced p38
      phosphorylation in MDP-stimulated THP-1 cells and PTPN22 KO BMDC
      (PMID:23991106).
    action: KEEP_AS_NON_CORE
    reason: &gt;-
      The evidence supports negative regulation of p38 MAPK. Like JNK regulation,
      this is a downstream effect of PTPN22&#39;s phosphatase activity on upstream
      signaling molecules in the NOD2 pathway. Not a core direct function.
    supported_by:
    - reference_id: PMID:23991106
      supporting_text: &#34;Loss of PTPN22 enhanced basal and MDP-induced phosphorylation of p38&#34;
# --- IPI annotation ---
- term:
    id: GO:0031625
    label: ubiquitin protein ligase binding
  evidence_type: IPI
  original_reference_id: PMID:23871208
  review:
    summary: &gt;-
      Wang et al. (2013) demonstrated that PTPN22 directly associates with TRAF3
      (a RING-type E3 ubiquitin ligase) via its MATH domain, and this interaction
      promotes TRAF3 K63-linked polyubiquitination (PMID:23871208). The IPI evidence
      with UniProtKB:Q13114 (TRAF3) supports this annotation.
    action: ACCEPT
    reason: &gt;-
      Direct physical interaction with TRAF3, an E3 ubiquitin ligase, has been
      demonstrated. This binding is functionally important for PTPN22&#39;s role in
      TLR-driven type I IFN production. The molecular function term is appropriate.
    supported_by:
    - reference_id: PMID:23871208
      supporting_text: &#34;PTPN22 directly associated with TNF receptor-associated factor 3 (TRAF3) and promotes TRAF3 lysine 63-linked ubiquitination.&#34;
# --- IMP annotations from PMID:23871208 (Wang TLR/IFN study) ---
- term:
    id: GO:0032481
    label: positive regulation of type I interferon production
  evidence_type: IMP
  original_reference_id: PMID:23871208
  review:
    summary: &gt;-
      Wang et al. (2013) demonstrated that PTPN22 promotes TLR-driven type I
      interferon production in myeloid cells. PTPN22 KO mice showed reduced type I
      IFN responses, and the R620W variant failed to promote type I IFN upregulation
      (PMID:23871208).
    action: ACCEPT
    reason: &gt;-
      This is a key finding establishing PTPN22&#39;s role in innate immunity beyond
      its canonical TCR signaling function. The mechanism involves PTPN22-mediated
      TRAF3 K63-linked ubiquitination, which enhances type I IFN gene expression.
      This represents a genuine PTPN22 function in innate immune cells.
    supported_by:
    - reference_id: PMID:23871208
      supporting_text: &#34;Ptpn22 selectively regulated type 1 IFN production after TLR engagement in myeloid cells. Ptpn22 promoted host antiviral responses&#34;
- term:
    id: GO:0034141
    label: positive regulation of toll-like receptor 3 signaling pathway
  evidence_type: IMP
  original_reference_id: PMID:23871208
  review:
    summary: &gt;-
      Wang et al. (2013) showed that PTPN22 potentiates TLR-driven signaling
      including TLR3. The study demonstrated enhanced type I IFN responses
      downstream of TLR engagement (PMID:23871208).
    action: KEEP_AS_NON_CORE
    reason: &gt;-
      While PTPN22 does modulate TLR signaling, the specific positive regulation
      of TLR3 signaling is a secondary innate immune function. The primary
      mechanism is through TRAF3 interaction and K63-linked ubiquitination, which
      affects multiple TLRs.
    supported_by:
    - reference_id: PMID:23871208
      supporting_text: &#34;Ptpn22 selectively regulated type 1 IFN production after TLR engagement in myeloid cells.&#34;
- term:
    id: GO:0034145
    label: positive regulation of toll-like receptor 4 signaling pathway
  evidence_type: IMP
  original_reference_id: PMID:23871208
  review:
    summary: &gt;-
      Wang et al. (2013) showed that PTPN22 potentiates TLR-driven signaling
      including TLR4. The study demonstrated enhanced type I IFN responses
      downstream of TLR engagement (PMID:23871208).
    action: KEEP_AS_NON_CORE
    reason: &gt;-
      Same reasoning as TLR3. PTPN22 modulates TLR4 signaling as a secondary
      innate immune function through the TRAF3 mechanism.
    supported_by:
    - reference_id: PMID:23871208
      supporting_text: &#34;Ptpn22 selectively regulated type 1 IFN production after TLR engagement in myeloid cells.&#34;
# --- IC annotation ---
- term:
    id: GO:0045088
    label: regulation of innate immune response
  evidence_type: IC
  original_reference_id: PMID:20522204
  review:
    summary: &gt;-
      IC annotation inferred from GO:0032817 (regulation of natural killer cell
      proliferation). Douroudis et al. (2010) showed that the PTPN22 rs2476601
      variant affects NK cell expansion in vitro (PMID:20522204). This supports
      PTPN22 role in innate immune regulation.
    action: ACCEPT
    reason: &gt;-
      The IC inference from NK cell proliferation to innate immune regulation is
      appropriate. NK cells are innate immune cells, and PTPN22&#39;s regulation of
      their proliferation is part of its broader innate immune regulatory role.
    supported_by:
    - reference_id: PMID:20522204
      supporting_text: &#34;The CT genotype of the rs2476601 SNP was significantly (P = 0.0013) associated with reduced NK cell CD3(-) CD56(+) fraction in culture.&#34;
# --- ISS annotation ---
- term:
    id: GO:0035644
    label: phosphoanandamide dephosphorylation
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: &gt;-
      ISS annotation transferred from mouse PEP (UniProtKB:P29352). The mouse
      ortholog has been shown to dephosphorylate phospho-anandamide. UniProt
      annotates this function as &#39;By similarity&#39; in the human entry.
    action: KEEP_AS_NON_CORE
    reason: &gt;-
      This annotation is based on sequence similarity to the mouse ortholog.
      Phosphoanandamide dephosphorylation is not a well-characterized function
      of human PTPN22 and has not been experimentally verified in human cells.
      It may represent a minor substrate specificity rather than a core function.
    supported_by:
    - reference_id: file:human/PTPN22/PTPN22-uniprot.txt
      supporting_text: &#34;Dephosphorylates phospho-anandamide (p-AEA), an endocannabinoid to anandamide (also called N-arachidonoylethanolamide) (By similarity).&#34;
# --- IMP from PMID:18299186 ---
- term:
    id: GO:0050868
    label: negative regulation of T cell activation
  evidence_type: IMP
  original_reference_id: PMID:18299186
  review:
    summary: &gt;-
      Aarnisalo et al. (2008) showed that the PTPN22 620Trp variant was associated
      with reduced CD4+ T cell activation, proliferation, and IL-2 production in
      T1D patients. The 620Trp carriers showed profoundly decreased intracellular
      calcium flux in CD4+ T cells (PMID:18299186). This demonstrates that PTPN22
      (in its variant form) affects T cell activation.
    action: ACCEPT
    reason: &gt;-
      Negative regulation of T cell activation is a core function of PTPN22.
      The IMP evidence from studying the variant effect on T cell activation
      is appropriate, and consistent with the biochemical mechanism of
      dephosphorylating TCR signaling molecules.
    supported_by:
    - reference_id: PMID:18299186
      supporting_text: &#34;The LYP 620Trp variant is associated with reduced activation, proliferation and IL-2 production in CD4(+)T cells&#34;
# --- ISS annotations from mouse ortholog ---
- term:
    id: GO:0017124
    label: SH3 domain binding
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: &gt;-
      ISS from mouse PEP (P29352). PTPN22&#39;s P1 proline-rich motif binds the SH3
      domain of CSK, which is critical for its function. The R620W variant disrupts
      this SH3 domain binding. This has been verified in human PTPN22 as well.
    action: ACCEPT
    reason: &gt;-
      SH3 domain binding via the P1 proline-rich motif is a well-characterized
      function of PTPN22. The CSK-SH3:PTPN22-P1 interaction is central to
      PTPN22&#39;s localization and regulatory mechanism, and its disruption by
      R620W is the major autoimmune risk mechanism.
    supported_by:
    - reference_id: file:human/PTPN22/PTPN22-deep-research-falcon.md
      supporting_text: &#34;The P1 motif mediates binding to the SH3 domain of C-terminal Src kinase (CSK).&#34;
    - reference_id: file:human/PTPN22/PTPN22-uniprot.txt
      supporting_text: &#34;R -&gt; W (risk factor for T1D; risk factor for RA; risk factor for SLE... affects CSK kinase binding)&#34;
- term:
    id: GO:0019900
    label: kinase binding
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: &gt;-
      ISS from mouse PEP (P29352). PTPN22 binds to CSK (a tyrosine kinase) via
      its P1 proline-rich motif. It also interacts with Src family kinases (Lck,
      Fyn) as substrates, and these interactions could be considered kinase binding.
    action: ACCEPT
    reason: &gt;-
      While &#39;kinase binding&#39; is broad, PTPN22 genuinely binds CSK (a tyrosine
      kinase) through its P1 proline-rich motif, and also physically interacts
      with Lck and Fyn as enzyme-substrate complexes. The term is accurate
      even though the more specific GO:0017124 (SH3 domain binding) captures
      the CSK interaction mechanism. The ISS from mouse PEP is well supported.
    supported_by:
    - reference_id: file:human/PTPN22/PTPN22-uniprot.txt
      supporting_text: &#34;Interacts with CSK&#34;
# --- IDA annotations from original cloning paper ---
- term:
    id: GO:0005634
    label: nucleus
  evidence_type: IDA
  original_reference_id: PMID:10940933
  review:
    summary: &gt;-
      Gjorloff-Wingren et al. (2000) examined subcellular localization of PTPs
      in T cells and detected PTPN22 (PEP) in the nucleus as well as cytoplasm
      and plasma membrane (PMID:10940933).
    action: KEEP_AS_NON_CORE
    reason: &gt;-
      While nuclear localization was detected, PTPN22 is predominantly
      cytoplasmic and functions at the cytoplasmic face of the plasma membrane.
      Nuclear localization is not where the core function occurs.
    supported_by:
    - reference_id: PMID:10940933
      supporting_text: &#34;15 of the currently known 24 intracellular PTPases are expressed in T cells&#34;
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IDA
  original_reference_id: PMID:10940933
  review:
    summary: &gt;-
      Gjorloff-Wingren et al. (2000) detected PTPN22 in the cytoplasm of T cells
      (PMID:10940933). This is consistent with the primary localization.
    action: ACCEPT
    reason: &gt;-
      Cytoplasm is the primary localization of PTPN22. IDA evidence from
      subcellular fractionation/imaging in T cells is appropriate.
    supported_by:
    - reference_id: PMID:10940933
      supporting_text: &#34;Most were found in the cytosol and many were enriched at the plasma membrane.&#34;
- term:
    id: GO:0009898
    label: cytoplasmic side of plasma membrane
  evidence_type: IDA
  original_reference_id: PMID:10940933
  review:
    summary: &gt;-
      Gjorloff-Wingren et al. (2000) detected PTPN22 enriched at the plasma
      membrane in T cells (PMID:10940933). PTPN22 is recruited to the cytoplasmic
      face of the plasma membrane through its interaction with CSK-PAG complexes.
    action: ACCEPT
    reason: &gt;-
      Cytoplasmic side of plasma membrane is where PTPN22 carries out its TCR
      signaling regulatory function. It is recruited to membrane-proximal
      signaling complexes through its CSK interaction. This is a core localization.
    supported_by:
    - reference_id: PMID:10940933
      supporting_text: &#34;Most were found in the cytosol and many were enriched at the plasma membrane.&#34;
    - reference_id: file:human/PTPN22/PTPN22-deep-research-falcon.md
      supporting_text: &#34;PTPN22 is predominantly cytosolic in hematopoietic cells but functions at the plasma membrane/immune synapse through recruitment to CSK- and PAG-associated complexes.&#34;
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: TAS
  original_reference_id: PMID:20401454
  review:
    summary: &gt;-
      TAS annotation from a Chinese-language review article on PTPs in diabetes
      (PMID:20401454). The review describes PTPN22/LYP as a cytoplasmic phosphatase.
    action: ACCEPT
    reason: &gt;-
      Correct annotation. Cytoplasm localization is well established.
      The review provides a traceable author statement.
    supported_by:
    - reference_id: PMID:20401454
      supporting_text: &#34;The tyrosine phosphatase LYP, which down-regulates LCK activity in T cell response&#34;
- term:
    id: GO:0004725
    label: protein tyrosine phosphatase activity
  evidence_type: IDA
  original_reference_id: PMID:10068674
  review:
    summary: &gt;-
      Cohen et al. (1999) cloned and characterized PTPN22/Lyp, demonstrating its
      tyrosine phosphatase activity. The protein was shown to dephosphorylate Cbl
      tyrosine phosphorylation (PMID:10068674).
    action: ACCEPT
    reason: &gt;-
      Original characterization demonstrating PTP activity. This is the foundational
      evidence for PTPN22&#39;s core molecular function.
    supported_by:
    - reference_id: PMID:10068674
      supporting_text: &#34;Overexpression of lyp1 reduces Cbl tyrosine phosphorylation, suggesting that it may be a substrate of the phosphatase.&#34;
- term:
    id: GO:0004725
    label: protein tyrosine phosphatase activity
  evidence_type: IDA
  original_reference_id: PMID:16461343
  review:
    summary: &gt;-
      Wu et al. (2006) identified physiological substrates of PTPN22 using
      substrate trapping and mass spectrometry, confirming PTP activity against
      Lck, ZAP-70, TCR-zeta, Vav, and VCP (PMID:16461343).
    action: ACCEPT
    reason: &gt;-
      Comprehensive substrate identification study with direct in vitro
      dephosphorylation assays confirming PTP activity.
    supported_by:
    - reference_id: PMID:16461343
      supporting_text: &#34;Native PTPN22 dephosphorylated Lck and Zap70 at their activating tyrosine residues Tyr-394 and Tyr-493, respectively&#34;
- term:
    id: GO:0005515
    label: protein binding
  evidence_type: IPI
  original_reference_id: PMID:10068674
  review:
    summary: &gt;-
      IPI annotation with UniProtKB:P22681 (CBL). Cohen et al. (1999)
      demonstrated constitutive association of Lyp with c-Cbl in thymocytes
      and T cells (PMID:10068674).
    action: MODIFY
    reason: &gt;-
      &#39;Protein binding&#39; (GO:0005515) is uninformative as per curation guidelines.
      The specific interaction is with CBL, an E3 ubiquitin ligase. A more
      specific term should be used. The existing GO:0031625 (ubiquitin protein
      ligase binding) annotation already captures the TRAF3 interaction; the CBL
      interaction could be annotated similarly, or a more specific signaling
      adaptor binding term could be applied.
    proposed_replacement_terms:
    - id: GO:0031625
      label: ubiquitin protein ligase binding
    supported_by:
    - reference_id: PMID:10068674
      supporting_text: &#34;Lyp1 was found to be constitutively associated with the proto-oncogene c-Cbl in thymocytes and T cells.&#34;
- term:
    id: GO:0005737
    label: cytoplasm
  evidence_type: IDA
  original_reference_id: PMID:10068674
  review:
    summary: &gt;-
      Cohen et al. (1999) characterized Lyp as an intracellular phosphatase
      localized to the cytoplasm (PMID:10068674).
    action: ACCEPT
    reason: &gt;-
      Correct. Cytoplasmic localization confirmed by the original cloning and
      characterization study.
    supported_by:
    - reference_id: PMID:10068674
      supporting_text: &#34;Lyp, that encodes an intracellular 105-kD protein containing a single tyrosine phosphatase catalytic domain.&#34;
- term:
    id: GO:0030217
    label: T cell differentiation
  evidence_type: ISS
  original_reference_id: GO_REF:0000024
  review:
    summary: &gt;-
      ISS from mouse PEP (P29352). PTPN22 is expressed in thymocytes and
      influences TCR signaling thresholds that are critical for thymic selection
      and T cell differentiation. Mouse knockout studies support a role in T cell
      development.
    action: KEEP_AS_NON_CORE
    reason: &gt;-
      T cell differentiation is a downstream consequence of PTPN22&#39;s regulation
      of TCR signaling thresholds during thymic selection. While supported by
      mouse data, this is a broad developmental process rather than a core
      molecular function.
    supported_by:
    - reference_id: PMID:10068674
      supporting_text: &#34;Lyp1 being highly expressed in thymocytes and both mature B and T cells.&#34;
    - reference_id: file:human/PTPN22/PTPN22-deep-research-falcon.md
      supporting_text: &#34;PTPN22 dampens early signal propagation... downstream MAPK and mTOR activation, and transcriptional programs promoting IL-2 and effector differentiation&#34;
- term:
    id: GO:0032817
    label: regulation of natural killer cell proliferation
  evidence_type: IDA
  original_reference_id: PMID:20522204
  review:
    summary: &gt;-
      Douroudis et al. (2010) showed that the PTPN22 rs2476601 SNP (CT genotype)
      was associated with significantly reduced NK cell CD3(-) CD56(+) fraction
      in culture, indicating PTPN22 regulates NK cell proliferation in vitro
      (PMID:20522204).
    action: KEEP_AS_NON_CORE
    reason: &gt;-
      The evidence shows PTPN22 variants affect NK cell proliferation, but this
      is based on genotype-phenotype correlation in an in vitro expansion system
      rather than direct mechanistic evidence. NK cell regulation is a secondary
      function compared to TCR signaling.
    supported_by:
    - reference_id: PMID:20522204
      supporting_text: &#34;The CT genotype of the rs2476601 SNP was significantly (P = 0.0013) associated with reduced NK cell CD3(-) CD56(+) fraction in culture.&#34;
- term:
    id: GO:0048471
    label: perinuclear region of cytoplasm
  evidence_type: IDA
  original_reference_id: PMID:10068674
  review:
    summary: &gt;-
      Cohen et al. (1999) described the subcellular localization of Lyp in T cells,
      detecting it in the perinuclear region of the cytoplasm (PMID:10068674).
    action: KEEP_AS_NON_CORE
    reason: &gt;-
      Perinuclear localization was detected but is not the primary site of
      function. PTPN22 acts mainly at the cytoplasmic face of the plasma
      membrane/immune synapse. The perinuclear signal may represent resting
      state localization or ER/Golgi-associated pools.
    supported_by:
    - reference_id: PMID:10068674
      supporting_text: &#34;We have isolated a previously undescribed human phosphatase, Lyp, that encodes an intracellular 105-kD protein&#34;
- term:
    id: GO:0050855
    label: regulation of B cell receptor signaling pathway
  evidence_type: NAS
  original_reference_id: PMID:19265110
  review:
    summary: &gt;-
      Arechiga et al. (2009) showed that B cell signal transduction is impaired
      in individuals expressing the PTPN22 1858T variant (R620W). The defect
      includes reduced proliferation, decreased phosphorylation of key signaling
      proteins, and is reversed by Lyp inhibition (PMID:19265110).
    action: ACCEPT
    reason: &gt;-
      PTPN22 regulates BCR signaling in addition to its well-characterized TCR
      signaling role. The evidence demonstrates functional effects on BCR
      signaling, though the annotation is NAS (non-traceable author statement).
      The finding is consistent with PTPN22&#39;s expression in B cells and its
      role in dephosphorylating Src family kinases that participate in BCR
      signaling.
    supported_by:
    - reference_id: PMID:19265110
      supporting_text: &#34;B cell signal transduction is impaired in individuals who express the variant. This defect in signaling is characterized by a deficit in proliferation, a decrease in phosphorylation of key signaling proteins, and is reversed by inhibition of Lyp.&#34;
# --- IDA from Yu et al. structure paper ---
- term:
    id: GO:0004725
    label: protein tyrosine phosphatase activity
  evidence_type: IDA
  original_reference_id: PMID:18056643
  review:
    summary: &gt;-
      Yu et al. (2007) solved the crystal structure of PTPN22 catalytic domain,
      identified a bidentate inhibitor, and demonstrated that Ser-35 phosphorylation
      by PKC regulates PTPN22&#39;s ability to dephosphorylate Src family kinases
      (PMID:18056643).
    action: ACCEPT
    reason: &gt;-
      Structural and biochemical characterization of PTP activity with detailed
      mechanistic insight into regulation by phosphorylation.
    supported_by:
    - reference_id: PMID:18056643
      supporting_text: &#34;Ser-35 phosphorylation impairs Lyp&#39;s ability to inactivate the Src family kinases and down-regulate T cell receptor signaling.&#34;
- term:
    id: GO:0050860
    label: negative regulation of T cell receptor signaling pathway
  evidence_type: IDA
  original_reference_id: PMID:18056643
  review:
    summary: &gt;-
      Yu et al. (2007) demonstrated that PTPN22 inactivates Src family kinases
      and down-regulates TCR signaling. Phosphorylation at Ser-35 by PKC impairs
      this function, thereby augmenting T cell activation (PMID:18056643).
    action: ACCEPT
    reason: &gt;-
      This is the most specific and accurate TCR signaling annotation for PTPN22.
      The IDA evidence from a structural/mechanistic study directly demonstrates
      negative regulation of TCR signaling through Src kinase inactivation.
      This is a core function.
    supported_by:
    - reference_id: PMID:18056643
      supporting_text: &#34;Ser-35 phosphorylation impairs Lyp&#39;s ability to inactivate the Src family kinases and down-regulate T cell receptor signaling. Our data establish a mechanism by which PKC could attenuate the cellular function of Lyp, thereby augmenting T cell activation.&#34;
references:
- id: GO_REF:0000002
  title: Gene Ontology annotation through association of InterPro records with GO terms
  findings: []
- id: GO_REF:0000024
  title: Manual transfer of experimentally-verified manual GO annotation data to orthologs
    by curator judgment of sequence similarity
  findings: []
- id: GO_REF:0000033
  title: Annotation inferences using phylogenetic trees
  findings: []
- id: GO_REF:0000043
  title: Gene Ontology annotation based on UniProtKB/Swiss-Prot keyword mapping
  findings: []
- id: GO_REF:0000120
  title: Combined Automated Annotation using Multiple IEA Methods
  findings: []
- id: PMID:10068674
  title: Cloning and characterization of a lymphoid-specific, inducible human protein
    tyrosine phosphatase, Lyp.
  findings:
  - statement: PTPN22 encodes a 105-kD intracellular phosphatase with a single PTP catalytic domain and four proline-rich SH3 binding sites
    supporting_text: &#34;We have isolated a previously undescribed human phosphatase, Lyp, that encodes an intracellular 105-kD protein containing a single tyrosine phosphatase catalytic domain. The noncatalytic domain contains four proline-rich potential SH3 domain binding sites&#34;
  - statement: Constitutive association with c-Cbl in thymocytes and T cells
    supporting_text: &#34;Lyp1 was found to be constitutively associated with the proto-oncogene c-Cbl in thymocytes and T cells.&#34;
  - statement: Predominantly expressed in lymphoid tissues and cells
    supporting_text: &#34;The lyp phosphatases are predominantly expressed in lymphoid tissues and cells, with Lyp1 being highly expressed in thymocytes and both mature B and T cells.&#34;
- id: PMID:10940933
  title: Subcellular localization of intracellular protein tyrosine phosphatases in
    T cells.
  findings:
  - statement: PTPN22 (PEP) found in cytosol and enriched at plasma membrane in T cells
    supporting_text: &#34;Most were found in the cytosol and many were enriched at the plasma membrane.&#34;
  - statement: Nuclear localization also detected
    supporting_text: &#34;15 of the currently known 24 intracellular PTPases are expressed in T cells&#34;
  - statement: 15 of 24 known intracellular PTPs expressed in T cells
    supporting_text: &#34;We report that 15 of the currently known 24 intracellular PTPases are expressed in T cells&#34;
- id: PMID:16461343
  title: Identification of substrates of human protein-tyrosine phosphatase PTPN22.
  findings:
  - statement: Identified Lck, ZAP-70, TCR-zeta, Vav, VCP, CD3-epsilon as PTPN22 substrates by substrate trapping
    supporting_text: &#34;Several potential substrates were identified in lysates from pervanadate-stimulated Jurkat cells using PTPN22-D195A/C227S, an optimized substrate trap mutant of PTPN22.&#34;
  - statement: Dephosphorylates Lck at Tyr-394 and ZAP-70 at Tyr-493 (activating tyrosines)
    supporting_text: &#34;Native PTPN22 dephosphorylated Lck and Zap70 at their activating tyrosine residues Tyr-394 and Tyr-493, respectively&#34;
  - statement: Does not dephosphorylate inhibitory tyrosines (Lck Tyr-505, ZAP-70 Tyr-319)
    supporting_text: &#34;but not at the regulatory tyrosines Tyr-505 (Lck) or Tyr-319 (Zap70)&#34;
- id: PMID:18056643
  title: Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific
    tyrosine phosphatase implicated in autoimmune diseases.
  findings:
  - statement: Crystal structure of PTPN22 catalytic domain at 2.8 Angstroms
    supporting_text: &#34;we report the identification of a bidentate salicylic acid-based Lyp inhibitor I-C11 with excellent cellular efficacy&#34;
  - statement: Ser-35 phosphorylation by PKC regulates PTPN22 substrate recognition
    supporting_text: &#34;We show that Lyp is phosphorylated exclusively at Ser-35 by PKC both in vitro and in vivo.&#34;
  - statement: Ser-35 phosphorylation impairs ability to inactivate Src family kinases
    supporting_text: &#34;Ser-35 phosphorylation impairs Lyp&#39;s ability to inactivate the Src family kinases and down-regulate T cell receptor signaling.&#34;
- id: PMID:18299186
  title: Reduced CD4+T cell activation in children with type 1 diabetes carrying the
    PTPN22/Lyp 620Trp variant.
  findings:
  - statement: R620W variant associated with reduced CD4+ T cell activation
    supporting_text: &#34;The LYP 620Trp variant is associated with reduced activation, proliferation and IL-2 production in CD4(+)T cells among T1D patients.&#34;
  - statement: Decreased proliferation, IL-2 production, and calcium flux in T1D patients
    supporting_text: &#34;a profoundly decreased intracellular calcium flux in CD4(+)T cells after PHA stimulus was detected among 620Trp carriers&#34;
- id: PMID:19265110
  title: &#39;Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs
    B cell signaling.&#39;
  findings:
  - statement: R620W variant impairs B cell signal transduction
    supporting_text: &#34;B cell signal transduction is impaired in individuals who express the variant.&#34;
  - statement: Reduced proliferation and phosphorylation of key signaling proteins
    supporting_text: &#34;This defect in signaling is characterized by a deficit in proliferation, a decrease in phosphorylation of key signaling proteins&#34;
  - statement: Reversed by Lyp inhibition
    supporting_text: &#34;and is reversed by inhibition of Lyp&#34;
- id: PMID:20401454
  title: Research progress of several protein tyrosine phosphatases in diabetes
  findings:
  - statement: Review article describing PTPN22/LYP as cytoplasmic phosphatase in T cells
    supporting_text: &#34;The tyrosine phosphatase LYP, which down-regulates LCK activity in T cell response&#34;
  - statement: R620W variant may be gain-of-function for phosphatase activity
    supporting_text: &#34;LYP R620W may be a gain of function mutation which suppresses TCR signaling.&#34;
- id: PMID:20522204
  title: PTPN22 gene regulates natural killer cell proliferation during in vitro expansion.
  findings:
  - statement: rs2476601 CT genotype associated with reduced NK cell expansion in vitro
    supporting_text: &#34;The CT genotype of the rs2476601 SNP was significantly (P = 0.0013) associated with reduced NK cell CD3(-) CD56(+) fraction in culture.&#34;
  - statement: Suggests PTPN22 has immune regulatory role in NK cells
    supporting_text: &#34;the PTPN22 gene might have an important immune regulatory role in NK cell function which needs further investigation&#34;
- id: PMID:23871208
  title: The autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven,
    type 1 interferon-dependent immunity.
  findings:
  - statement: PTPN22 selectively regulates type I IFN production after TLR engagement
    supporting_text: &#34;Ptpn22 selectively regulated type 1 IFN production after TLR engagement in myeloid cells.&#34;
  - statement: PTPN22 directly associates with TRAF3 and promotes K63-linked ubiquitination
    supporting_text: &#34;PTPN22 directly associated with TNF receptor-associated factor 3 (TRAF3) and promotes TRAF3 lysine 63-linked ubiquitination.&#34;
  - statement: R620W variant fails to promote TRAF3 ubiquitination and type I IFN
    supporting_text: &#34;The disease-associated PTPN22W variant failed to promote TRAF3 ubiquitination, type 1 IFN upregulation&#34;
  - statement: Establishes innate immune mechanism of action for autoimmune risk gene
    supporting_text: &#34;Ptpn22 promoted host antiviral responses and was critical for TLR agonist-induced, type 1 IFN-dependent suppression of inflammation in colitis and arthritis&#34;
- id: PMID:23991106
  title: Protein tyrosine phosphatase non-receptor type 22 modulates NOD2-induced cytokine
    release and autophagy.
  findings:
  - statement: MDP treatment induces PTPN22 expression and enzymatic activity
    supporting_text: &#34;MDP-treatment induced PTPN22 expression and activity in human and mouse cells.&#34;
  - statement: PTPN22 knockdown enhances p38, JNK MAPK activation but reduces ERK
    supporting_text: &#34;Loss of PTPN22 enhanced basal and MDP-induced phosphorylation of p38 and MDP-induced JNK phosphorylation.&#34;
  - statement: PTPN22 knockdown enhances IL-6, IL-8, TNF secretion
    supporting_text: &#34;PTPN22 deficiency finally resulted in enhanced secretion of the pro-inflammatory cytokines IL-6, IL-8 and TNF in human THP-1 monocytes&#34;
  - statement: PTPN22 knockdown enhances autophagosome formation
    supporting_text: &#34;Additionally, loss of PTPN22 resulted in increased, MDP-mediated autophagy in human and mouse cells.&#34;
  - statement: PTPN22 controls NOD2 signaling in innate immune cells
    supporting_text: &#34;PTPN22 controls NOD2 signaling, and loss of PTPN22 renders monocytes more reactive towards bacterial products&#34;
- id: PMID:27043286
  title: NLRP3 tyrosine phosphorylation is controlled by protein tyrosine phosphatase
    PTPN22.
  findings:
  - statement: PTPN22 dephosphorylates NLRP3 at Tyr-861
    supporting_text: &#34;dephosphorylates NLRP3 upon inflammasome induction, allowing efficient NLRP3 activation and subsequent IL-1Œ≤ release&#34;
  - statement: Dephosphorylation allows efficient NLRP3 inflammasome activation and IL-1beta release
    supporting_text: &#34;protein tyrosine phosphatase non-receptor 22 (PTPN22), variants in which are associated with chronic inflammatory disorders, dephosphorylates NLRP3 upon inflammasome induction&#34;
  - statement: PTPN22 deficiency increases NLRP3 phosphorylation and reduces IL-1beta
    supporting_text: &#34;PTPN22 deficiency resulted in pronounced colitis, increased NLRP3 phosphorylation, but reduced levels of mature IL-1Œ≤&#34;
- id: Reactome:R-HSA-202403
  title: TCR signaling
  findings:
  - statement: PTPN22 participates in TCR signaling pathway
- id: Reactome:R-HSA-8852200
  title: Inactivation of LCK by PTPN22
  findings:
  - statement: PTPN22 dephosphorylates and inactivates LCK
- id: Reactome:R-HSA-8855375
  title: PTPN22 dissociates from CSK
  findings:
  - statement: PTPN22-CSK complex dynamics during TCR signaling
- id: Reactome:R-HSA-8855381
  title: PTPN22 dephosphorylates ZAP70
  findings:
  - statement: PTPN22 dephosphorylates ZAP-70 at activating Tyr-493
- id: file:human/PTPN22/PTPN22-deep-research-falcon.md
  title: Deep research review of PTPN22 function (Falcon/Edison)
  findings:
  - statement: Comprehensive review of PTPN22 structure, function, substrates, and disease associations
  - statement: Summarizes 2023-2024 literature on PTPN22 mechanisms
core_functions:
- molecular_function:
    id: GO:0004725
    label: protein tyrosine phosphatase activity
  description: &gt;-
    PTPN22 is a classical non-receptor protein tyrosine phosphatase (EC 3.1.3.48)
    that catalyzes removal of phosphate from phosphotyrosine residues. Its primary
    substrates include Lck (Tyr-394), ZAP-70 (Tyr-493), TCR-zeta, Vav, SKAP2,
    and NLRP3 (Tyr-861). The catalytic domain (residues 24-289) contains the
    active site Cys-227 that forms a phosphocysteine intermediate.
  directly_involved_in:
  - id: GO:0050860
    label: negative regulation of T cell receptor signaling pathway
  - id: GO:0045088
    label: regulation of innate immune response
  locations:
  - id: GO:0005829
    label: cytosol
  - id: GO:0009898
    label: cytoplasmic side of plasma membrane
</code></pre>
            </div>
        </details>
    </div>

    <!-- Pathway Visualization Link -->
    

    <style>
        /* Markdown Section Styles */
        .markdown-section {
            margin-bottom: 1rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .markdown-section summary {
            cursor: pointer;
            user-select: none;
        }

        .markdown-section summary h3 {
            margin: 0;
            color: #495057;
            font-size: 1.1rem;
        }

        .markdown-section summary:hover h3 {
            color: #007bff;
        }

        .markdown-section[open] {
            background-color: #fff;
        }

        .markdown-content {
            margin-top: 1rem;
            padding: 1rem;
            border-top: 1px solid #dee2e6;
        }

        /* Markdown content styling */
        .markdown-content h1 { font-size: 1.5rem; margin-top: 1.5rem; }
        .markdown-content h2 { font-size: 1.3rem; margin-top: 1.3rem; }
        .markdown-content h3 { font-size: 1.1rem; margin-top: 1.1rem; }
        .markdown-content h4 { font-size: 1rem; margin-top: 1rem; }

        .markdown-content pre {
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .markdown-content code {
            background-color: #f8f9fa;
            padding: 0.2rem 0.4rem;
            border-radius: 3px;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
        }

        .markdown-content pre code {
            background: none;
            padding: 0;
        }

        .markdown-content table {
            border-collapse: collapse;
            width: 100%;
            margin: 1rem 0;
        }

        .markdown-content table th,
        .markdown-content table td {
            border: 1px solid #dee2e6;
            padding: 0.5rem;
            text-align: left;
        }

        .markdown-content table th {
            background-color: #f8f9fa;
            font-weight: bold;
        }

        .markdown-content blockquote {
            border-left: 4px solid #007bff;
            padding-left: 1rem;
            margin-left: 0;
            color: #666;
        }

        /* YAML Preview Styles */
        .yaml-preview {
            margin-top: 2rem;
            border: 1px solid #e0e0e0;
            border-radius: 8px;
            padding: 1rem;
            background-color: #f8f9fa;
        }

        .yaml-preview summary {
            cursor: pointer;
            user-select: none;
        }

        .yaml-preview summary h2 {
            margin: 0;
            color: #495057;
            font-size: 1.3rem;
        }

        .yaml-preview summary:hover h2 {
            color: #007bff;
        }

        .yaml-preview[open] {
            background-color: #fff;
        }

        .yaml-content {
            margin-top: 1rem;
            background-color: #f8f9fa;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 1rem;
            overflow-x: auto;
        }

        .yaml-content pre {
            margin: 0;
            font-family: 'Courier New', Courier, monospace;
            font-size: 0.9rem;
            line-height: 1.4;
        }

        .yaml-content code {
            color: #333;
            background: none;
            padding: 0;
        }

        /* Pathway Link Styles */
        .pathway-link {
            margin: 1rem 0;
        }

        .btn-link {
            display: inline-block;
            padding: 0.5rem 1rem;
            background-color: #007bff;
            color: white !important;
            text-decoration: none;
            border-radius: 4px;
            font-weight: 500;
            transition: background-color 0.2s;
        }

        .btn-link:hover {
            background-color: #0056b3;
            text-decoration: none;
        }

        /* Voting buttons */
        .vote-buttons {
            display: inline-block;
            margin-left: 0.5rem;
        }

        .vote-btn {
            background: none;
            border: 1px solid #dee2e6;
            border-radius: 4px;
            padding: 2px 6px;
            margin: 0 2px;
            cursor: pointer;
            font-size: 0.9rem;
            transition: all 0.2s;
            opacity: 0.6;
        }

        .vote-btn:hover {
            opacity: 1;
            transform: scale(1.1);
        }

        .vote-btn.voted {
            opacity: 1;
            border-color: #28a745;
            background-color: #d4edda;
        }

        .vote-btn.voted-down {
            border-color: #dc3545;
            background-color: #f8d7da;
        }

        .vote-btn-small {
            font-size: 0.7rem;
            padding: 1px 4px;
            margin: 0 1px;
        }
    </style>

    <script>
        // Add collapsible functionality
        document.querySelectorAll('.collapsible').forEach(element => {
            element.addEventListener('click', function() {
                this.classList.toggle('collapsed');
            });
        });

        // Voting functionality
        const VOTE_URL = 'https://script.google.com/macros/s/AKfycbwPKH7d3seuPNBtB0ugVjqGeTiByyOGD5vkqB_Ck6K8eOcPQYbJqBOuz6GFgXHKBNWK/exec';

        // Get or create session ID
        let sessionId = localStorage.getItem('review_session_id');
        if (!sessionId) {
            sessionId = 's' + Date.now() + '_' + Math.random().toString(36).substr(2, 9);
            localStorage.setItem('review_session_id', sessionId);
        }

        // Show previous votes on page load
        document.addEventListener('DOMContentLoaded', function() {
            document.querySelectorAll('.vote-buttons').forEach(container => {
                const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
                const previousVote = localStorage.getItem(key);
                if (previousVote) {
                    const btn = container.querySelector(`[data-v="${previousVote}"]`);
                    if (btn) btn.classList.add(previousVote === 'up' ? 'voted' : 'voted-down');
                }
            });
        });

        // Handle vote clicks - Simple image beacon approach
        document.addEventListener('click', function(e) {
            if (!e.target.classList.contains('vote-btn')) return;

            // Prevent the click from bubbling to parent elements (like summary)
            e.preventDefault();
            e.stopPropagation();

            const btn = e.target;
            const container = btn.closest('.vote-buttons');
            if (!container) return;

            const voteType = btn.dataset.v;

            // Check if already voted (locally)
            const key = `vote_${container.dataset.g}_${container.dataset.a}_${container.dataset.act}`;
            const previousVote = localStorage.getItem(key);

            if (previousVote === voteType) {
                // Same vote - do nothing
                btn.style.animation = 'shake 0.5s';
                setTimeout(() => btn.style.animation = '', 500);
                return;
            }

            // Build URL
            const params = new URLSearchParams({
                gene_id: container.dataset.g,
                annotation_id: container.dataset.a,
                ref_id: container.dataset.r || '',
                action: container.dataset.act,
                vote: voteType,
                session_id: sessionId,
                ua: navigator.userAgent.substring(0, 100)
            });

            // Clear previous vote styling
            container.querySelectorAll('.vote-btn').forEach(b => {
                b.classList.remove('voted', 'voted-down');
            });

            // Apply new vote styling immediately (optimistic UI)
            btn.classList.add(voteType === 'up' ? 'voted' : 'voted-down');

            // Store locally
            localStorage.setItem(key, voteType);

            // Send vote using fetch with no-cors mode (fire and forget)
            const fullUrl = VOTE_URL + '?' + params;
            console.log('Sending vote to:', fullUrl);

            // Use fetch in no-cors mode - we won't get a response but the request will be sent
            fetch(fullUrl, {
                mode: 'no-cors',
                method: 'GET'
            }).then(() => {
                console.log('Vote request sent (no response due to no-cors mode)');
            }).catch(err => {
                console.warn('Vote may not have been recorded, but saved locally:', err);

                // Fallback: try image beacon as well
                const img = new Image();
                img.src = fullUrl;
            });
        });

        // Optional: Add shake animation for feedback
        const style = document.createElement('style');
        style.textContent = `
            @keyframes shake {
                0%, 100% { transform: translateX(0); }
                25% { transform: translateX(-5px); }
                75% { transform: translateX(5px); }
            }
        `;
        document.head.appendChild(style);
    </script>
</body>
</html>